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Abstract

RELATIONSHIPS AMONG PARKINSON’S DISEASE SYMPTOMS, STIGMA, AND
MENTAL HEALTH: A STRENGTHS-BASED PERSPECTIVE
By Richard S. Henry, M.A., M.S.
A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of
Philosophy at Virginia Commonwealth University
Virginia Commonwealth University, 2020
Major Director: Paul B. Perrin, Ph.D., Associate Professor of Psychology, Director, Health
Psychology, Department of Psychology
As rates of Parkinson’s disease (PD) increase, so does the need to examine some of the negative
social consequences experienced by people with PD. Symptoms of PD have been linked to
greater experiences of stigma, and the more visible symptoms of PD increase an individual’s
likelihood for experiencing stigmatization and social rejection. Individuals who experience high
levels of stigma generally have poorer mental health outcomes. While these relationships are
well documented, little is known about whether stigma mediates the relationship between PD
symptoms and mental health outcomes. Additionally, some past research suggests that the
personal strengths of social support and spirituality may moderate the relationship between
stigma and mental health in other populations; however, no research has examined the potential
moderating effects of these variables in individuals with PD. This study sought to examine the
connections among PD symptoms, stigma, and mental health, as well as examine social support
and spirituality as potential buffers. This study represents a secondary data analysis of clinical
data reflecting these constructs collected from 392 individuals with PD being seen at a PD
specialty clinic affiliated with an academic medical center. Results showed stigma partially
mediated the relationship between both motor and non-motor symptoms and mental health
vii

problems. There was also a moderating effect of social support on the relationships among
motor/non-motor symptoms, stigma, and mental health problems, with stronger indirect effects at
low levels of social support, suggesting that this mediational model held only for individuals
with low social support. Spirituality moderated the relationships among motor/non-motor
symptoms, stigma, and mental health problems, with stronger indirect effects at lower levels of
spirituality, again suggesting that this mediational model held only for those with low or midlevels of spirituality. Implications of these results are that health professionals working with
individuals with PD may wish to consider stigma and discrimination in how they present and
design treatment options for PD patients. Interventions designed to increase and foster social
support among individuals with PD, such as helping individuals maintain a number of positive
close relationships, may have beneficial mental health effects. Also, including an assessment of
spiritual practice and beliefs into patient assessments may help health care providers better
understand an individual with PD’s worldview, and subsequently view of chronic illness, if there
is a spiritual community of support, and if spiritual interventions and coping mechanisms may be
appropriate and helpful for the individual.
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Chapter 1
Overview
This manuscript will begin by discussing the prevalence of Parkinson’s disease (PD). To
date, the causes of PD are not yet known, and as such there are no definitive diagnostic tests for
PD. This is followed by a discussion of PD etiology, the progression of the disease, and attempts
at defining different stages of PD. The clinical presentation of PD can vary by the individual, and
stages are not always linear. The next section will discuss treatment of PD. Although there are no
neuroprotective therapies and no cure for PD, there are some pharmacological therapies aimed at
reducing PD symptoms to improve quality of life. It will be illustrated that individuals with PD
often experience stigma as a result of the negative social interpretations of the symptomatic
movements of PD. The Minority Stress Model will be used to illustrate how stigma may account
in part for the relationship between PD symptoms and negative mental health. This is followed
by research exploring the protective factors of social support and spirituality for individuals with
PD from experiences of stigma. The objectives of the current study will be discussed next
followed by the methods, data analysis plan, and a discussion of the potential implications of the
results.
Epidemiology
A progressive neurodegenerative disease, Parkinson’s disease (PD) over time leads to
both cognitive impairment (Petrou, Dwamena, Foerster, MacEachern, Bohnen, Müller, et al.,
2015) and physical disability (Shulman et al., 2016). An individual’s independent functioning
may be limited as a result of these impairments and disabilities. In the United States, PD is the
second most common progressive neurodegenerative disease (de Lau & Breteler, 2006). PD
affects approximately 1% of individuals over the age of 60 (Nussbaum & Ellis, 2003), and other
rates suggest about 1 to 2 individuals per 1,000 (Tysnes & Storstein, 2017). By 2030, an
1

estimated 1.2 million individuals will be living with PD in the US (Marras et al., 2018). The
increases in number of PD cases is due to both proportions of the older adult population with PD
increasing and the overall number of older adults in the population increasing (Dorsey & Bloem,
2018; Marras et al., 2018). PD is an age-related disease, with prevalence increasing with age, and
onset is rare before the age of 50 (Muangpaisan et al., 2011; Rocca, 2018; Savica et al., 2018).
While estimates vary, approximately 1% of adults over the age of 60 are affected by PD in
industrialized countries (Nussbaum & Ellis, 2003), this number increases to approximately 2.6%
of adults over the age of 85 who are affected (Pringsheim et al., 2014).
Age is a commonly accepted risk factor for PD (Collier et al., 2017). Other potential risk
factors include environmental toxins, drugs, pesticides, brain microtrauma, and genetics
(Cacabelos, 2017). However, there remains conflicting evidence around a number of risk factors
including gender, ethnicity, living circumstances, and occupations (Ball et al., 2019). All these
factors have been suspected in heightened PD risk, although the evidence remains conflicted.
Disease Course and Diagnosis
The etiology of PD is still not fully understood, despite ongoing research examining the
underlying causes. PD represents multi-level system dysfunction with widespread involvement
of other body systems (Caviness, 2014; Ehgoetz Martens & Lewis, 2017). First, cellular and
tissue abnormalities occur as a result of genetic influences. As a result of these abnormalities, the
dopamine neurons in the substantia nigra region of the brain are damaged, altered, or killed
(Caviness, 2014). The resulting decrease in dopamine plays a critical role in the development of
the motor symptoms of the disease, and ultimately influences an individual’s behavior (Caviness,
2014). Genetic mutations are still not able to explain the majority of PD cases, despite the efforts
to identify these mutations (Caviness, 2014; de Lau & Breteler, 2006). As approximately 90% of

2

PD cases are sporadic (de Lau & Breteler, 2006), there may be other important factors—such as
exposure to environmental toxins (Ball et al., 2019; Cacabelos, 2017)—which contribute to the
development of PD.
There is not currently a definitive diagnostic test for PD, and as a result PD may be
difficult to diagnose due to the similarities it shares with other neurological conditions. While
diagnostic certainty is not possible during an individual’s life (Postuma et al., 2015), postmortem
confirmation of diagnoses using neuropathological criteria may occur (Adler et al., 2019; Gibb &
Lees, 1988). Research using postmortem confirmation suggests a diagnostic accuracy which
ranges between 75-95% (Hughes, Daniel, Kilford, & Lees, 1992; Hughes, Giobbie-Hurder,
Weaver, Kubal, & Henderson, 1999; Litvan et al., 1998; Tolosa, Wenning, & Poewe, 2006).
Consequently, a clinical diagnosis of PD is based on the presence of characteristic motor
symptoms, how the individual responds to L-Dopa, and additional associated inclusionary and
exclusionary symptoms (Rao et al., 2003).
As a progressive condition, there have been many attempts to define and outline the
stages and progression of PD (Goetz et al., 2004; Owen et al., 1993; Starkstein, Bolduc, Preziosi,
& Robinson, 1989). One of the mostly commonly used systems was outlined by Hoehn and Yahr
in which five stages were identified (Hoehn & Yahr, 1967). The first stage generally has
unilateral involvement and is characterized by minimal to no functional impairment. The second
stage is defined by bilateral involvement; however, balance is usually not impaired. In the third
stage, individuals may still be able to take care of themselves, unsteadiness first begins to appear,
and individuals may not be able to maintain their balance when standing if pushed. PD is
considered fully developed and severely disabling by stage four. Individuals may still be able to
stand or walk without assistance at this point. In the fifth stage, individuals are often confined to
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a bed or wheelchair. It is important to note that progression through these stages may not always
be linear (Poewe, 2006). One example of this is that there are typically greater declines in motor
function earlier in the disease than later (Poewe, 2006).
PD itself is not usually fatal; rather, individuals with PD often die of complications from
later stages of the disease and comorbidities (Beyer et al., 2001; Bugalho et al., 2019; Paul et al.,
2019; Wermuth et al., 1995). PD has several different phenotype varieties, all of which are
progressive (Evans et al., 2011). While clinical presentation varies, early physical symptoms may
include bradykinesia (slow movements), stiffening muscles, hand tremors, sleep disruption,
speech changes, and decreased facial expressivity (Jankovic, 2008; Mosley et al., 2017). Along
with the physical symptoms, both early cognitive and emotional changes may occur such as
feeling depressed, anxious, or fearful and difficulty concentrating (Weintraub & Burn, 2011).
The progression of physical symptoms includes loss of muscle control which may lead to
difficulty swallowing, urinary incontinence, and bowel dysfunction (NINDS, 2019). Patients
may also experience hallucinations, delusions, and dementia as the disease progresses and during
pharmacological treatment (Mosley et al., 2017; Weintraub & Burn, 2011).
Life expectancy of individuals with PD is thought to be reduced (Elbaz et al., 2003;
Morens et al., 1996). Individuals with PD will live 15 years post-diagnosis on average (Lees et
al., 2009). However, due to treatment advances, some individuals with PD are living even longer
(Lee & Gilbert, 2016). Due to the variation in disease progression, disease course may be greatly
impacted by age of diagnosis. Studies suggest that individuals who are diagnosed younger tend
to live longer post-diagnosis than individuals who are diagnosed when they are older (Ishihara et
al., 2007).
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Symptoms
The clinical presentation of PD can vary by patient and is very similar to other
neurological conditions. Symptoms of PD have been classified by symptom type (e.g., motor
aspects of experiences of daily living, non-motor experiences of daily living, cognitive
impairment, depressed/anxious mood, etc.) for both diagnostic and research purposes (Goetz et
al., 2008; Peto et al., 1998). Motor symptoms, including bradykinesia, postural instability, resting
tremor (shaking while in a relaxed state), and akinesia (loss or impaired voluntary movement)
have historically been characteristic of PD (Mandir & Vaughan, 2000). Additional motor
symptoms may also be present, including reduced facial expression (Ricciardi et al., 2015) and
gait issues (Forsaa et al., 2015). While motor Parkinsonism remains a prominent feature of the
disease, the non-motor manifestations of PD have received increased attention. Individuals will
generally present numerous non-motor symptoms by 10 years post-diagnosis (Poewe, 2006).
Non-motor symptoms of PD may include cognitive impairment, apathy, depression, anxiety,
sleep disruption, psychosis, and dementia (Mosley et al., 2017).
Treatment
To date, there is no neuroprotective therapy for PD (AlDakheel et al., 2014) and no cure
(Connolly & Lang, 2014). There are pharmacological therapies aimed at reducing symptoms to
improve quality of life. Pharmacological interventions are usually pursued when individuals with
PD experience impairment or embarrassment from their symptoms (Connolly & Lang, 2014).
While symptoms are mild, generally in the early stages of the disease, monoamine oxidase type
B inhibitors (MAOBIs) such as rasagiline or selegiline might be prescribed to reduce symptoms
(Ives et al., 2004). Additionally, in the early stages of PD and once activities of daily living
become impaired, dopamine agonists or levodopa (L-dopa) may be effective treatments
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(Connolly & Lang, 2014; Fox et al., 2011). L-dopa is one of the most common pharmacological
treatments for PD (Mandir & Vaughan, 2000).
Individuals with PD have depleted levels of dopamine in the brain, and the role of L-dopa
is to raise dopamine levels (Connolly & Lang, 2014). Administration of L-dopa is typically done
in combination with a decarboxylase inhibitor—carbidopa—which prevents the conversion of Ldopa to dopamine and helps maximize the delivery to the brain (Mandir & Vaughan, 2000). Ldopa has been associated with reductions in freezing, somnolence, edema, risk of impulse control
disorders, and hallucinations compared to dopamine agonists (Ferreira et al., 2013) and is
considered to be one of the most effective pharmacological treatments currently available for PD
(Mandir & Vaughan, 2000).
As the disease progresses, PD becomes more resistant to treatment, as non-dopaminergic
brain regions are increasingly affected (Connolly & Lang, 2014). The degenerative processes
that cause PD are not directly influenced by dopamine treatments (Korczyn & Hassin-Baer,
2015). Pharmacologic interventions for patients have yet to catch-up or benefit from advances in
understandings of the genetic contributions, molecular mechanisms, and pathology of PD
(Suchowersky et al., 2006). Additionally, while PD symptoms may be decreased using dopamine
agonists and L-dopa, there are many potential side effects. Adverse side effects from the
medications may include dyskinesias (i.e., involuntary muscle movements), nausea, psychosis,
dopamine dysregulation syndrome, impulsive behaviors (Connolly & Lang, 2014).
Stigma in PD
Individuals with PD often experience stigma as a result of the negative social
interpretations of the symptomatic movements such as rigidity, reduced facial expressions, and
tremors (Moore & Knowles, 2006). Goffman defined stigma as “the situation of the individual
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who is disqualified from full social acceptance” (1963, pg. 3). An individual once stigmatized
becomes discounted and tainted, no longer a whole person (Goffman, 1963). In addition to being
stigmatized for symptomatic movements of PD, PD symptoms are often mistaken for other
stigmatized conditions. For example, movement disorders may be misinterpreted as drunkenness,
or difficulty in speech or communication may be mistaken for an intellectual disability (Moore &
Knowles, 2006). Greater risk of stigmatization and social rejection occur with more visible PD
symptoms (Hermanns, 2013). Individuals with PD employ a number of strategies to hide their
symptoms and avoid stigmatization, by reducing communication or placing their hands in their
pockets (Burgener & Berger, 2008; Hermanns, 2013). In several studies, both the general public
and medical professionals across cultures (Taiwan and the US) rated individuals with PD as less
friendly, happy, and social due to speech production difficulties and facial masking symptoms
(Hemmesch et al., 2009; Jaywant & Pell, 2010; Tickle-Degnen et al., 2011). Awareness of
stigmatization and negative interpretations of the PD symptoms by individuals with PD may
result in isolation and social withdrawal behaviors (Burgener & Berger, 2008). PD stigma has
been significantly correlated with negative quality of life (Ma et al., 2016).
Stigmatization of individuals with PD have been directly linked to PD symptoms. These
symptoms include facial masking (Gunnery et al., 2015; Hemmesch, 2014; Hermanns, 2013),
dystonias, akinesia (Chapuis et al., 2004), restless leg syndrome (Fereshtehnejad et al., 2015),
postural instability, bradykinesia, rigidity, and tremors (Lyons et al., 1997). It has been suggested
that stigma often arises from PD motor symptoms, as these symptoms are viewed by others as
signs of fragility (Maffoni et al., 2017). Increased rates of depression, anxiety, and negative selfimage have also been linked to experiences of stigma in PD (Hatzenbuehler et al., 2013; Mak et
al., 2007; Meyer, 2003; Pascoe & Smart Richman, 2009). Previous research in general
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populations has found strength-based factors, for example coping and resilience, weakened the
strength of associations between stigma and adverse mental health outcomes (Bockting et al.,
2013; Hatzenbuehler et al., 2013; Meyer, 2003); however, these relationships have not been
examined in the context of PD. To date, very few studies have examined the psychosocial
strengths of patients with PD to decrease experiences of stigma, improve mental health
outcomes, and improve adjustment to the diagnosis. A better understanding of strength-based
factors and their relationship to stigma may improve quality of life in individuals with PD and
possibly their daily functioning.
Mental Health and PD
Apathy, anxiety, and depression are extremely common among individuals with PD
(Kano et al., 2011; Pagonabarraga et al., 2015; Quelhas & Costa, 2009). A formal clinical
diagnosis of PD may only occur once motor symptoms are present. It was originally thought
non-motor symptoms (NMS) only occurred in later stages, but it is now known they may be
manifest at any stage (Kano et al., 2011). Previous research suggests that anxiety may be present
very early in the disease, a finding which held even when examining medical histories up to 20
years prior to the first motor symptom (Kano et al., 2011). These mental health issues can be
exacerbated by stigma experienced as a result of having PD (Oguru et al., 2010). Comorbid
mental health diagnoses can strongly negatively impact the quality of life of individuals with PD
and that of their caregivers (Brok et al., 2015; Kano et al., 2011; Quelhas & Costa, 2009).
Apathy. Apathy is considered a behavioral syndrome which has behavioral, cognitive,
and affective features and is defined by decreased motivation, reduced interests or emotions, and
decreased goal-directed behaviors which cannot be attributed to other cognitive impairment or
emotional distress (Pagonabarraga et al., 2015). Maintenance of motivation is attributed to
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subcortical structures, specifically the link between the limbic system and prefrontal cortex.
Disruption of these networks, as occurs in PD, alters the ability to associate complex stimuli with
emotions (Pagonabarraga et al., 2015). Apathy is the clinical manifestations of these changes.
Along with apathy being clinically significant to PD, motivation is an important psychological
feature to overall mental well-being. Motivation promotes goal-driven behaviors and sustaining
those goal-directed behaviors (Pagonabarraga et al., 2015). An absence of self-initiated goaldirected behaviors as seen in apathy is sometimes described as an indifference or flattening of
affect (Pagonabarraga et al., 2015).
There is a high prevalence of apathy in PD which can greatly influence the quality of life
of both individuals with PD and their caregivers (Pagonabarraga et al., 2015). Apathy is seen in
approximately 20-36% of newly diagnosed individuals, with a decrease among those
subsequently treated with dopaminergic treatments (Pagonabarraga et al., 2015). The prevalence
of apathy is higher among PD patients with dementia (60% vs 40%, 5-10 years post diagnosis)
(Pagonabarraga et al., 2015). A meta-analysis found an overall prevalence of about 40%, with
apathy present without depression or cognitive impairment in half of cases (Brok et al., 2015).
Apathy was also associated with more severe disability, older age, increased motor symptoms,
depression, worse cognitive function, and potentially lower quality of life and increased
caregiver burden (Brok et al., 2015). Previous research has also shown that apathy is strongly
associated with stigma and cognitive symptoms (Oguru et al., 2010).
Apathy is frequently seen in PD, as a unique symptom or syndrome independent of
depression—although it is conventionally considered a clinical symptom of depression. A review
of apathy found three possible explanations for apathy in PD (Bogart, 2011). First, research has
suggested links among dopamine depletion and basal ganglia dysfunction in PD and apathy—an
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endogenous explanation. Second, activity restriction and disability from PD may lead to
apathy—an exogenous explanation. Finally, methodological confounds and conceptual problems
may be obscuring the relationship between apathy and PD (Bogart, 2011). However, as one of
the most debilitating and common non-motor manifestations of PD (Martínez-Horta et al., 2014;
Starkstein, 2012), for the purposes of this study, apathy will be included as a mental health
outcome given its potential to add a heavy burden for the individual with PD and potential to
operate differently than either depression or anxiety.
Anxiety. In PD, the most common anxiety disorders include panic disorder, phobic
disorder, social phobia, and generalized anxiety disorder (Kano et al., 2011; Pontone et al., 2009;
Walsh & Bennett, 2001). Anxiety is characterized by worry, fear, and apprehension (Kano et al.,
2011). Clinically significant anxiety prevalence is estimated in between 25% to 40% of
individuals with PD (Kano et al., 2011; Pontone et al., 2009; Quelhas & Costa, 2009; Starkstein,
Robinson, Leiguarda, & Preziosi, 1993; Walsh & Bennett, 2001). It has been posited that anxiety
may be a response to the PD symptoms (Walsh & Bennett, 2001). There are several factors
which may perpetuate anxiety throughout the disease course, including worrying about the risk
of falls and disturbances in balances and unexpected fluctuations in symptoms, as well as social
anxiety, a fear of negative evaluation in public (Walsh & Bennett, 2001). For example,
individuals may become self-conscious or embarrassed by their motor impairments such as their
stooped posture, shuffling gait, and tremor (Quelhas & Costa, 2009). This negative evaluation
may also be stigmatization, the consequences of which may include anxiety and social
withdrawal. Anxiety has been significantly associated with decreased quality of life among
individuals with PD, perhaps even more so than depression (Kano et al., 2011; Pontone et al.,
2009; Quelhas & Costa, 2009).
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Depression. Clinical depression includes consistent symptoms for at least a two week
period in which an individual has a depressed mood, loss of interest or pleasure in daily
activities, fatigue, weight loss, and insomnia (Kano et al., 2011). The prevalence of depression is
estimated between 4% to 70%, although common ranges are between 30-45% of individuals with
PD will experience clinically significant depression (Quelhas & Costa, 2009). Variation in
estimates may be the result of how depression is being measured and the specific PD population
being surveyed. Previous studies have correlated depression with duration of illness, severity of
impairments, and cognitive deficits (Starkstein et al., 1993). Research suggests that depression is
a main factor related to negative quality of life for individuals with PD (Quelhas & Costa, 2009).
Strength-Based Factors
There has been limited research with individuals with PD exploring the strength-based,
protective factors of social support and spirituality. However, research in both general and PD
populations has demonstrated that social support and spirituality may protect against a variety of
mental health problems (Brod et al., 1998; Reynolds, 2017), stigma, and decreased quality of life
(Reynolds, 2017; Schrag et al., 2003).
Social Support. Social support is not well understood for individuals with PD, and is
most often studied in conjunction with depression (Schreurs et al., 2000). Studies of social
support for individuals with PD generally examine one’s perceptions of support from others,
such as support from family and friends or difficulties in close relationships (Peto et al., 1995,
1998). However, for both PD and other chronic illnesses, some studies have shown that social
support from close relationships does not differ as a function of disease severity (Fitzpatrick,
Peto, Jenkinson, Greenhall, & Hyman, 1997; Fitzpatrick, Newman, Lamb, & Shipley, 1988).
Individuals with PD who are less satisfied with their social relationships and experience lower
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social support are more likely to experience higher rates of anxiety, depression, stress, and
decreased quality of life (Brod et al., 1998; Fleminger, 1991; Simpson et al., 2006; Takahashi et
al., 2016). Social support has also been associated with positive well-being (e.g., happiness),
suggesting that it is not just psychological distress but well-being that may be influenced by
social support (MacCarthy & Brown, 1989). A study by Schrag and colleagues (2003) compared
age of PD onset, and individuals with younger onset PD experienced greater disruption of their
family and social lives and higher rates of perceived stigmatization.
Spirituality. Spirituality has been identified in extant literature as a form of coping with
chronic illness (Reynolds, 2017), which includes individuals with PD. Research has
demonstrated that individuals with a spiritual life and/or committed religious orientation tend to
have lower rates of depression and anxiety, better ability to cope, and greater overall quality of
life (Harris et al., 2010; Reynolds, 2017; Rowe & Allen, 2004; Shafranske & Malony, 1990;
Unantenne et al., 2013). However, the research focused on spiritual coping for PD is extremely
limited. Spirituality often refers to purpose, meaning, transcendence, connectedness, or direction,
although a precise and universal definition is not agreed upon (Reynolds, 2017). Spiritual coping
for individuals with PD may include using spirituality to cope with their disease, accepting and
adjusting to their diagnosis, and maintaining hope (Soundy et al., 2014). For some, the ritual of
prayer is also utilized for healing, managing the disease, and in making decisions (Soundy et al.,
2014). In a qualitative study of 56 PD patients, five themes related to spiritual coping emerged:
(1) feeling a sense of gratitude; (2) connecting with individuals; (3) depending on faith; (4)
providing meaning to PD; and (5) prayer (Reynolds, 2017). Using spirituality for coping is not
just limited to living with a chronic illness, but can also assist with other health-related
challenges including apathy, anxiety, depression, and stigma (Hermanns, 2013; Reynolds, 2017).
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Theoretical Model
A very common theoretical framework for explaining stigma and health risks is the
Minority Stress Model (Meyer, 2003). This framework was developed to explain sexual minority
health disparities through their experiences of chronic stress, hostility, harassment, victimization,
and discrimination (Meyer, 2003). In other words, the chronic, unique, and socially based
stressors faced by sexual minorities related to their identities will negatively impact their mental
health (Meyer, 2003). This model includes a variety of stressors and coping mechanisms and the
resulting mental health outcomes (Meyer, 2003). While this framework was originally developed
and validated in a sexual minority adult population, it has been adapted for a variety of minority
populations (Meyer et al., 2008) including individuals with general disabilities (Conover &
Israel, 2019).
The Minority Stress Model can be used to assess a variety of relationships related to the
experiences of individuals with PD. Symptoms of PD lead to individuals with PD experiencing
stigma and discrimination (Moore & Knowles, 2006). Individuals with PD also experience high
rates of apathy, anxiety, and depression (Kano et al., 2011; Pagonabarraga et al., 2015; Quelhas
& Costa, 2009). Previous research in other populations has documented that experiences of
discrimination are predictive of higher levels of mental health issues (Burgener & Berger, 2008;
Maffoni et al., 2017; Sutter & Perrin, 2016). Additionally, there is some evidence that social
support and spirituality may be able to mitigate the link between discrimination and mental
health, although these effects have not been documented in people with disabilities (Brewster et
al., 2016; Ojeda & Piña-Watson, 2013).
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The Current Study
As the prevalence of PD increases, so does the need to examine some of the negative
social consequences. Previous literature has linked symptoms of PD to increased experiences of
stigma (Moore & Knowles, 2006). Experiences of stigma may result in PD patients withdrawing
socially and isolating themselves (Burgener & Berger, 2008), which ultimately may lead to
poorer mental health outcomes (Hatzenbuehler et al., 2013; Mak et al., 2007; Meyer, 2003;
Pascoe & Smart Richman, 2009). Despite the clear correlations among symptoms, stigma, and
mental health problems, there is relatively little research examining the potential mediation effect
of stigma on the relationship between symptoms and poor mental health. Specifically, mood and
motor symptoms have been linked, such that as motor symptoms decline so do mood symptoms
(Marsh, 2013). Additionally, relatively little research has examined the roles of social support
and spirituality as protective factors. Therefore, the purpose of this study was to examine the
connections among PD symptoms (motor and non-motor), stigma, and mental health problems,
as well as examine whether social support and spirituality moderated these relationships.
Hypothesis 1: Research has linked various types of PD symptoms with stigma (Moore &
Knowles, 2006). Accordingly, it was hypothesized that increased PD symptoms (motor and nonmotor) will be associated with higher levels of stigma.
Hypothesis 2: Previous research has demonstrated a link between stigma with increased
apathy, anxiety, and depression (Hatzenbuehler et al., 2013; Meyer, 2003; Oguru et al., 2010).
Therefore, it was hypothesized that stigma will be associated with higher levels of mental health
issues (i.e., apathy, anxiety, and depression).
Hypothesis 3: There is research linking PD symptoms and stigma for individuals with
PD (Moore & Knowles, 2006). There have also been relationships between stigma and mental
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health issues (Hatzenbuehler et al., 2013; Meyer, 2003; Oguru et al., 2010). Given these
previously uncovered relationships, it was hypothesized that stigma will mediate the relationship
between PD symptoms (motor and non-motor) and mental health (i.e., apathy, anxiety, and
depression).
Hypothesis 4: There has been limited research exploring relationships among social
support, PD symptoms, stigma, and mental health in individuals with PD. However, research has
demonstrated that social support may protect against a variety of mental health problems (Brod
et al., 1998; Simpson et al., 2006), stigma (Schrag et al., 2003), and decreased quality of life
(Takahashi et al., 2016). Based upon the literature review, it was hypothesized that social support
will moderate relationships among PD symptoms (motor and non-motor), stigma, and mental
health problems, such that higher levels of social support will weaken these relationships.
Hypothesis 5: Research with individuals with PD has not explored relationships among
spirituality, PD symptoms, stigma, and mental health problems. However, research has
demonstrated that spirituality may protect against a variety of mental health problems, stigma,
and decreased quality of life (Hermanns, 2013; Reynolds, 2017). It was therefore hypothesized
that spirituality will moderate the relationships among PD symptoms (motor and non-motor),
stigma, and mental health, such that higher levels of spirituality will weaken these relationships.
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Chapter 2
Methods
Participants
Participants (N = 392) were Parkinson’s disease (PD) patients at a multidisciplinary PD
clinic in a public, academic medical center in the Mid-Atlantic region of the US. To be eligible
to participate in the study, PD patients had to: (a) be enrolled in the clinic’s research registry, (b)
have a physician diagnosis of PD, (c) have baseline (first appointment data), (d) be over the age
of 18, and (e) be able to read and respond in English. Individuals were ineligible to participate if:
(a) their primary diagnosis was any non-PD movement disorder diagnosis or unknown clinical
movement disorder or (b) they had comorbid psychiatric and neurologic diagnoses such as
bipolar disorder, schizophrenia, epilepsy, or head injury.
Demographic information for participants appears in Table 1. The sample was
predominately White, male, and with at least some college education. While the mean age was
nearly 70 years old, the youngest participant was 36 and oldest was 88.
Table 1. Sample Characteristics
Characteristics
(N = 392)
Age, M (SD)
68.11 (8.78)
Race/Ethnicity n (%)
Caucasian/White
357 (91.1)
African American/Black
25 (6.4)
Hispanic/Latino
3 (0.8)
Asian
3 (0.8)
Middle Eastern
1 (0.3)
Indian
2 (0.5)
Native American
1 (0.3)
Sex n (%)
Female
141 (36.0)
Male
251 (64.0)
Years of Education, M (SD)
15.24 (2.97)
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A post-hoc power analysis was conducted to determine if the proposed analyses would be
adequately powered given the sample size. Using G*Power 3.1 (Faul et al., 2007), for a
moderated mediation (the analysis with the greatest number of parameters with five predictors
and one criterion variable) a sample size of 392, a .05 alpha level, and power at .80 (1-β), the
current sample size would be able to identify all large-, medium-, and small-sized effects > f =
.04.
Procedure
A research registry was queried for all individuals with PD’s first neuropsychological
evaluation who meet the study inclusion criteria. These individuals had undergone a
neuropsychological evaluation at the multidisciplinary PD clinic between 2011 and 2019 and
consented to have their data included into the clinic’s research registry for ongoing and future
research. As part of the clinical neuropsychological evaluation, individuals with PD completed
pencil and paper self-report measures examined in the current study in private clinic rooms. The
neuropsychological evaluation varied by clinician; as such, individuals included in the registry
may have being assessed using different measures of the same construct. PD symptoms, stigma,
and social support were assessed through the Parkinson’s Disease Questionnaire-39. PD
symptoms were also assessed via the Non-Motor Symptoms Questionnaire (PD-NMS). Apathy
was measured using the Apathy Scale. Anxiety was measured using the Generalized Anxiety
Disorder-7 or Beck Anxiety Inventory, depression was measured using the Patient Health
Questionnare-9, Beck Depression Inventory-II, or Geriatric Depression Scale-Short Form, and
spirituality was assessed using one item of the Linear Analogue Self-Assessment. A variety of
demographic information was also obtained including age, race/ethnicity, gender, education,
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marital status, work status and work history. The study was approved by the institution’s ethical
review board.
Measures
In order to create indices of motor and non-motor symptoms and mental health, measures
reflecting these constructs were comprised of items from several PD and mental health
questionnaires. This section will first describe the questionnaires themselves and then describe
the process for identifying the specific items for inclusion and exclusion, as well as the
combination process.
Parkinson’s Disease Questionnaires-39 (PDQ-39). The PDQ-39 was used to assess PD
symptoms, stigma, and social support (Peto et al., 1998). The stigma and social support subscales
were used. The remaining items were evaluated and sorted into motor and non-motor symptom
categories as described below. Subscale scores (included motor and non-motor symptoms) were
obtained by totaling the raw score, dividing by the total number of items in the subscale, and
multiplying by 100. Scores range from 0 (no problem at all) to 100 (maximum possible score)
for each subscale, with higher scores representing greater symptoms, higher stigma, or lower
social support. In a validation study of the PDQ-39, internal validity was acceptable or better for
all subscales (expect social support at time one; α = .76), and the internal reliability for the total
score was good (α = .84, .89) across two clinical samples (Peto et al., 1998). In the current study,
the internal reliability of the total scale was excellent (α = .96); by subscales the internal
reliability of mobility (α = .94), cognitions (α = .73), bodily discomfort (α = .73), activities of
daily living (α = .89), emotional well-being (α = .90), stigma (α = .87), and social support (α =
.74) were acceptable to excellent.
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Non-Motor Symptoms Questionnaire (NMS). Symptoms of PD were also assessed
using the 30-item NMS (Martinez-Martin et al., 2007). Individuals are presented a range of
possible problems they may have experienced in the previous month and asked to respond “yes”
or “no” as to whether they have experienced the symptom. Each “yes” response is given a value
of one and a total score is calculated, with higher scores representing more severe symptoms.
Items were evaluated and sorted into motor and non-motor symptom categories as described
below. Internal reliability averaged across nine domains was questionable (α = .61) in a pilot
study (Chaudhuri et al., 2007). In the current study, the internal reliability of the scale was good
(α = .81).
Apathy Scale (AS). Apathy was assessed using the 14-item AS (Starkstein et al., 1992).
Items use a four-point Likert-type scale, with total scores ranging from 0 to 42. Higher scores
represent higher apathy. A score of 14 or higher indicates clinically significant levels of apathy
in PD. This scale had acceptable internal reliability (α = .76) in validation studies with PD
patients (Starkstein et al., 1992). In the current study, the internal reliability of the full scale was
good (α = .80), and with two excluded items was acceptable (α = .77).
Generalized Anxiety Disorder-7 (GAD-7). Anxiety was assessed using the GAD-7
(Spitzer et al., 2006). Individuals use a Likert-type scale ranging from 0 (“not at all”) to 3
(“nearly every day”) to respond to seven items. Total scores are summed with possible scores
ranging from 0 to 21. Scores of 0 to 4 indicate minimal severity, 5 to 9 mild severity, 10 to 14
moderate severity, and 15 to 21 severe anxiety. This scale had excellent internal reliability (α =
.92) in a validation study of primary care clinic patients (Spitzer et al., 2006). In the current
study, the internal reliability of the full scale was excellent (α = .91).
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Beck Anxiety Inventory (BAI). Anxiety was also be assessed using the BAI (Beck,
Epstein, Brown, & Steer, 1988). The 21-item scale response options range from 0 (“not at all) to
3 (“severely – it bothered me a lot”). Scores of 0-7 reflect minimal anxiety, 8-15 mild anxiety
16-25 moderate anxiety, and 26-63 severe anxiety. This scale has excellent internal reliability (α
= .92) in a validation study of psychiatric outpatients (Beck, Epstein, Brown, & Steer, 1988). In
the current study, the internal reliability of the full scale was good (α = .88), and with nine
excluded items was good (α = .83).
Beck Depression Inventory-II (BDI-II). Depression was assessed using the BDI (Beck,
Steer, & Brown, 1996; Dozois, Dobson, & Ahnberg, 1998). This 21-item self-report measure has
response items on a four-point scale. Scores of 0-13 indicate minimal depression, 14-19 mild,
20-28 moderate, and 29-63 severe. This scale has excellent internal consistency among college
students (α = .93) and clinical outpatients (α = .92) (Beck et al., 1996; Dozois et al., 1998). In the
current study, the internal reliability of the full scale was excellent (α = .90), and with three
excluded items was excellent (α = .90).
Patient Health Questionnare-9 (PHQ-9). Depression was measured using the PHQ-9
(Kroenke et al., 2001). Responses to this nine-item measure are on a Likert-type scale ranging
from 0 (“not at all”) to 3 (“nearly every day”). Total scores are summed, with 5 to 9 indicating
mild, 10 to 14 moderate, 15 to 19 moderately severe, and 20 to 27 severe depressive
symptomatology. This scale had good internal reliability (α = .89) in a validation study of
primary care clinic patients (Kroenke et al., 2001). In the current study, the internal reliability of
the full scale was good (α = .86), and with two excluded items was good (α = .84).
Geriatric Depression Scale Short Form (GDS-SF). The GDS-SF was also be used to
assess depression (Sheikh & Yesavage, 1986). This scale is a 15-item self-report measure with
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“yes/no” response options. Scores of 0-4 are normal, 5-8 mild, 8-11 moderate, and 12-15 severe
depression. This scale had excellent internal reliability (α = .92) in a study of Parkinson’s
patients (Ertan et al., 2005). In the current study, the internal reliability of the full scale was good
(α = .85), and with one excluded item was good (α = .84).
Linear Analogue Self-Assessment (LASA). Spirituality was assessed using the LASA
(Locke et al., 2007). The LASA comprises of five quality of life items—including spirituality—
with functioning of each rated on zero to ten scale (zero being the worst, ten being the best).
Only the single spirituality item will be used for this study.
Measure Screening
The motor and non-motor symptom measures were composed of items from both the
PDQ-39 and NMS. Duplicate items were screened for across the PDQ-39 and NMS. Using
current PD criteria of motor and non-motor symptoms and clinician review, items were coded as
either motor or non-motor. Four duplicate items were found, and the NMS items were retained,
as the PDQ-39 are often considered quality of life measures. Six items from the PDQ-39 were
eliminated as they overlapped with mental health constructs. This left 21 items other than the
stigma and social support items. One item was rejected because it did not fit clear symptom
categories and appeared to more closely approximate the stigma items. This left 16 items that
were coded as motor and four non-motor from the PDQ-39. From the NMS, three items were
coded as motor based on clinician review, and 22 were coded as non-motor. Three items were
excluded for duplicating mental health constructs, and two were excluded for not clearly fitting
into motor or non-motor categories. Overall, 19 items were coded as motor and 26 non-motor.
For scoring purposes, items were converted into z-scores and summed.
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The mental health composite variable was the average of completed mental health scores
including the apathy z-score, anxiety z-score (averaged if both measures completed), and
depression z-score (averaged across completed measures). To be included, participants had to
have completed at least two of three mental health domains (i.e., apathy, anxiety, and
depression). The mental health measures all had the physical health and PD symptoms removed,
which resulted in nine items being excluded from the BAI, three from the BDI-II, two from the
PHQ-9, and one from the GDS-SF. The mental health scales were also examined for overlapping
constructs, which resulted in two items being excluded from apathy.
Data Analysis Plan
In addition the eligibility criteria, data was further screened whereby individuals must
have completed (a) at least 50% of items by subscale for the PDQ-39, (b) at least two out of three
indices of mental health with at least 50% of items completed, (c) at least 50% of items
completed on the NMS. A Little’s missing completely at random (MCAR) test was run to
examine if data is missing at random. Following the MCAR test, missing data was imputed using
expectation maximization.
Preliminary Analyses. Prior to conducting the primary statistical analyses to investigate
the study’s hypotheses, normality tests (i.e., skewness and kurtosis) were performed to establish
if the study scales and subscales are distributed normally. Skewness and kurtosis were identified
using a critical value of 2.0. If abnormal distributions are detected, data transformation were
employed where appropriate for corrections. Multicollinearity was assessed via correlation
coefficients among all independent variables (with a goal of r < .70 among all predictors).
Primary Analyses. Two base mediations and four moderated mediation models were developed
using the PROCESS macro (Hayes, 2017). In the mediation models (Model 4), motor or non-
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motor PD symptoms were specified to lead to stigma, which was then specified to lead to a
composite (average z-score) mental health variable comprised of apathy, anxiety, and/or
depression; see Figure 1). The mediations were examined differentially as a function of
participants’ social support and spirituality (Model 59; Figure 2). To address H1 and H2, the
direct effects of PD symptoms to stigma and stigma to mental health problems were examined
(see Figure 1).
Figure 1
Conceptual Model of Proposed mediation of PD Symptoms, Stigma, and Mental Health
Problems

To address H3, the indirect effects of PD symptoms to mental health problems through stigma
was examined (see Figure 1). The interactions of the moderated mediations (social support and
spirituality; see Figure 2) were examined to address H4 and H5.
Figure 2
Conceptual Model of Proposed moderated mediation of PD Symptoms, Stigma, and Mental
Health Problems by Social Support or Spirituality
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To identify unique contributions among patterns of connections among PD symptoms,
stigma, and mental health problems in individuals with PD, a series of simultaneous multiple
regressions were performed. The first regression included the motor and non-motor PD
symptoms as the predictors and stigma as the criterion variable. The second through fourth
regressions included motor and non-motor PD symptoms as the predictors and mental health
problems (i.e., one each for apathy, anxiety, and depression) as the criterion variable. For any
demographic variable shown in a correlation matrix to be associated with an outcome, that
demographic variable was controlled for in the regression models.
Results
Preliminary Analyses
Data cleaning. In addition the eligibility criteria, data was further screened whereby
participants must have completed (a) at least 50% of items by subscale for the PDQ-39, (b) at
least two out of three indices of mental health with at least 50% of items completed, (c) at least
50% of items completed on the NMS. To determine whether data were missing at random, a
Little’s missing completely at random (MCAR) test was conducted. Data were determined to be
missing at random for apathy (three missing; p = .925), BAI (five missing; p = .519), and GAD-7
(one missing; p = .288); however, not for the PHQ-9 (p =.001), from which only two responses
were missing. There were no missing data in the PDQ-39, NMS, BDI-II, and GDS-SF.
Following the MCAR test, missing item-level data were imputed using expectation maximization
within the same scale.
Normality and multicollinearity assumptions. Normality tests (i.e., skewness and
kurtosis) were performed to establish if the study scales and subscales were distributed normally.
Skewed or kurtotic variables were identified using a critical value of +/- 2.0 (see Table 2).
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Table 2. Skewness and Kurtosis Statistics for Study Variables
Variable
Skewness
Kurtosis
Motor Symptoms
1.12
0.63
Non-motor Symptoms
0.82
0.76
Stigma
1.77
3.05
Mental Health Problems
1.03
1.37
Social Support
-2.25
5.62
Spirituality
-1.06
1.02
Most variables were generally within the cutoff or slightly above for both skewness and kurtosis,
social support was very kurtotic. Data transformations were attempted; however, the original
variable was retained as attempts at transformations only increased how kurtotic the variable
was. Next a correlation matrix was created with all variables (see Table 3).
Table 3. Correlations of Primary Study Variables
1
2
3
1. Motor Symptoms
2. Non-motor Symptoms
.610**
3. Stigma
.478** .402**
4. Social Support
-.426** -.522** -.445**
5. Spirituality
-.287** -.363** -.273**
6. Mental Health Problems .475** .592** .439**
Note. ** p < .01

4

5

.383**
-.450**

-.528**

Additionally, a correlation matrix was created to examine bivariate relationships among
demographic variables (age, sex, and years of education) and study variables (see Table 4).
Table 4. Correlation Matrix with Demographic Variables
Sex (0 = female,
Variable
Age
Education
1 = male)
Motor Symptoms
.110*
-.078
-.186**
Non-motor Symptoms
-.079
-.151**
-.144**
Stigma
-.277**
-.050
-.108*
Social Support
.111*
.099*
.023
Spirituality
.048
.061
-.008
Mental Health Problems
-.100*
-.068
-.219**
Note. *p < .05, **p < .01
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No data exceeded the threshold (r < .70 among all predictors) for multicollinearity via
correlation coefficients among all independent variables.
Motor symptoms were positively correlated with non-motor symptoms. Both symptoms
types were positively correlated with stigma and mental health problems, and negatively
correlated with social support and spirituality. Stigma was negatively correlated with social
support and spirituality, and positively correlated with mental health problems. Social support
and spirituality were positively correlated with each other, and both negatively correlated with
mental health problems. Age was positively associated with motor symptoms and social support,
and negatively associated with stigma and mental health problems. Sex was negatively
associated with non-motor symptoms such that females reported more non-motor symptoms, and
positively associated with social support such that males reported higher levels of social support.
Education was negatively correlated with motor symptoms, non-motor symptoms, stigma, and
mental health problems.
Outliers. The database was checked for univariate and multivariate outliers. To assess for
univariate outliers, the motor symptoms, non-motor symptoms, stigma, mental health composite,
spirituality, and social support variables were all converted into z-scores. A cutoff of =/- 3.0 was
used to identify univariate outliers. Only stigma (2.6%) and social support (2.8%) exceeded the
1% recommendation for retention by Cohen et al. (2003). As the outliers were not extreme, had
reasonable values, and still a small proportion of the sample, all the data were retained.
To identify multivariate outliers, Mahalanobis distance (D2) was computed. With five
degrees of freedom and at α = .001, the critical value for detecting multivariate outliers was +/20.515. Three multivariate outliers were identified, with the following critical values: 31.587,
29.243, and 27.796. These participants responses were reviewed again, and although extreme,
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they were generally consistent with expected patterns. For example, the person with the highest
Mahalanobis distance had high symptoms, high stigma, high mental health problems, and low
social support. As the three multivariate outliers generally fell within expected patterns without
appearing otherwise random or problematic, their scores were retained.
Descriptive statistics. The descriptive statistics (i.e., means, standard deviations) of
participants’ symptoms, stigma, mental health (apathy, anxiety, and depression), social support,
and religious well-being appear in Table 5.
Table 5. Means and Standard Deviations for Study Variables.
Variable
N
Mean (SD)
Range
Motor symptoms
392
9 (5.4)
0-19
Non-motor symptoms
392
9 (4.4)
0-23
Stigma
392
16.20 (21.20)
0-100
Social Support
392
90.10 (17.03)
8.33-100
Spirituality
349
7.77 (2.02)
0-10
Apathy
390
11.60 (5.92)
0-34
Anxiety
BAI
274
9.68 (7.67)
0-40
GAD-7
158
4.28 (4.92)
0-21
Depression
BDI
287
9.69 (7.61)
0-45
PHQ-9
155
6.26 (5.52)
0-25
GDS-SF
70
4.19 (3.58)
0-14
Note. The means and ranges reflect all items in the original measure.
Based on the clinical cutoff of 14 for apathy, 30.5% of individuals had significant levels of
apathy. Of those who completed the BAI, 43.8% had minimal anxiety, 37.2% had mild anxiety,
14.2% had moderate anxiety, and 4.7% severe anxiety. Of those who completed the GAD-7,
65.2% had minimal, 20.9% had mild, 8.2% had moderate, and 5.7% had severe anxiety. Of those
who completed the BDI-II, 76.0% had minimal, 13.9% had mild, 7.3% had moderate, and 2.8%
had severe depression. Of those who completed the PHQ-9, 28.4% had mild, 12.3% had
moderate, 5.8% had moderately severe, and 4.5% had severe depression. Of those who
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completed the GDS-SF, 61.4% were in the normal range, 27.1% mild and 11.5% moderate, and
nobody scored in the severe depression range.
Primary Analyses
Two base mediation models expanded into four moderated mediation models were
developed using the PROCESS macro (Hayes, 2017). In these models, motor or non-motor PD
symptoms were specified to lead to stigma, which was then specified to lead to a composite (zscore average) mental health variable comprised of apathy, anxiety, and depression. The
mediations were examined differentially as a function of participants’ social support and
spirituality (Figure 2).
Mediations: The Hayes PROCESS macro was used to conduct two meditational models
(Model 4) to examine patterns of relationships that emerged among the primary study variables.
In the first mediation, motor PD symptoms was specified to have a direct effect on mental health
problems, as well as an indirect effect through stigma, using 5,000 bootstrap samples. The direct
paths from motor PD symptoms to stigma (b = .037, p < .001) and from stigma to mental health
problems (b = .204, p < .001) were both statistically significant. Further, the indirect effect of
motor PD symptoms on mental health problems through stigma was statistically significant (b =
.008, 95% CI [.004, .012]), indicating a partial mediation because the direct path from motor PD
symptoms to mental health problems was still statistically significant in the model (b = .020, p <
.001).
For the second mediation, non-motor PD symptoms was specified to have a direct effect
on mental health problems, as well as an indirect effect through stigma, using 5,000 bootstrap
samples. The direct paths from non-motor PD symptoms to stigma (b = .038, p < .001) and from
stigma to mental health problems (b = .178, p < .001) were both statistically significant. Further,
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the indirect effect of non-motor PD symptoms on mental health problems through stigma was
statistically significant (b = .007, 95% CI [.003, .011]), indicating a partial mediation because the
direct path from non-motor PD symptoms to mental health problems was still statistically
significant in the model (b = .035, p < .001).
Moderated mediation: Motor PD symptoms as predictor and social support as
moderator. In the first moderated mediation (Model 59), motor PD symptoms was specified to
have a direct effect on mental health problems, as well as an indirect effect through stigma, using
5,000 bootstrap samples. The direct paths from motor PD symptoms to stigma (b = .352, p <
.001) and from stigma to mental health problems (b = .106, p = .006) were both statistically
significant. Further, the direct path from motor PD symptoms to mental health problems was
statistically significant in the model (b = .232, p < .001).
Next it was examined whether the mediational effect from motor PD symptoms through
stigma to mental health problems differed as a function of participants’ level of social support.
The overall model predicting mental health problems was significant, F(5, 386) = 41.276, p <
.001, R2 = .348. Table 6 presents the b-weights, standard errors, p-values, and 95% bias-correct
bootstrap confidence intervals for each of the paths included in the moderated-mediation model.
The motor PD symptoms x social support interaction with stigma as the criterion variable was
not significant (b = -.001, p = .978). When mental health problems were the criterion, the
interactions between motor PD symptoms x social support (b = .088, p = .003; Figure 3) and
stigma x social support (b = -.081, p = .002; Figure 4) were significant. A regression was run to
examine a potential effect of multicollinearity (due to two interaction terms being used in the
same PROCESS model) on the direction of the motor PD symptoms x social support moderation,
as the effect of high social support is not in the expected direction. While the overall model was
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significant F(3, 388) = 56.511, p < .001, R2 = .304, the interaction was not (β =.073, p = .161).
This suggests that the direction may be an artifact of multicollinearity in the model.
Table 6. Model Summary for the Association between Motor PD Symptoms and Mental Health
Problems through Stigma by Social Support (N = 392).
95% Bias-corrected bootstrap
Social Support
Estimate (SE)
confidence interval
Model 1: DV = Stigma
.35(.05)***
.26 to .44
Motor Symptoms
Social Support
-.29(.05)***
-.40 to -.19
Motor Symptoms × Social Support
-.001(.03)
-.07 to .07
2
R
.30***
Model 2: DV = Mental Health
.23 (.04)***
.16 to .30
Motor Symptoms
.11(.04)**
.03 to .18
Stigma
Social Support
-.18(.04)***
-.26 to -.10
Motor Symptoms × Social Support
.09(.03)**
.03 to .15
Stigma × Social Support
-.08(.03)**
-.13 to -.03
2
.35***
R
Note. 5,000 bootstrap samples. DV = dependent variable. **p < .05. ***p < .001.
Figure 3

Mental Health Problems

Moderation of motor PD symptoms to mental health by levels of social support found to be an
artifact of multicollinearity
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Figure 4

Mental Health Problems

Moderation of stigma to mental health by levels of social support
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Follow-up analyses examined the conditional effects at different levels of the moderator
(social support). There were conditional direct and indirect effects of motor PD symptoms on
mental health problems by social support. Specifically, motor PD symptoms had a larger direct
effect on mental health problems for participants with high social support relative to those with
low social support, suggesting an accelerating effect of social support on this direct effect
inconsistent with H4 but reflective of error and an artifact of multicollinearity devoid of meaning
(Table 7). Conversely, the indirect effect of motor PD symptoms on mental health problems
through stigma was stronger at lower levels of social support than at high levels, suggesting that
this mediational model held only for those with low social support and therefore a buffering
effect consistent with H4 and supporting a moderated mediation (Table 8).
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Table 7. Conditional Direct Effects of Motor PD Symptoms on Mental Health Problems at
Levels of Social Support (N = 392)
Social
Support

Effect

Estimate (SE)

95% Bias-corrected bootstrap confidence
interval

Low
.15*
.04
.07 to .24
High
.28*
.04
.20 to .37
Note. *Effects are considered statistically significant if the p value is < .05 and the 95% biascorrected bootstrap confidence interval does not encapsulate zero.
Table 8. Conditional Indirect Effects of Motor PD Symptoms on Mental Health Problems at
Levels of Social Support (N = 392)
Social
Support

Effect

Estimate (SE)

95% Bias-corrected bootstrap confidence
interval

Low
.06*
.02
.02 to .11
High
.02
.02
-.02 to .06
Note. *Effects are considered statistically significant if the 95% bias-corrected bootstrap
confidence interval does not encapsulate zero.
Moderated mediation: Non-motor symptoms as predictor and social support as
moderator. In the second moderated mediation (Model 59), non-motor PD symptoms was
specified to have a direct effect on mental health problems, as well as an indirect effect through
stigma, using 5,000 bootstrap samples. The direct paths from non-motor PD symptoms to stigma
(b = .229, p < .001) and from stigma to mental health problems (b = .130, p < .001) were both
statistically significant. Further, the direct path from non-motor PD symptoms to mental health
problems was statistically significant in the model (b = .341, p < .001).
Next, it was examined whether the mediational effect from non-motor PD symptoms
through stigma to mental health differed as a function of participants’ level of social support. The
overall model predicting mental health was significant, F(5, 386) = 55.182, p < .001, R2 = .417.
Table 9 presents the b-weights, standard errors, p-values, and 95% bias-correct bootstrap
confidence intervals for each of the paths included in the moderated-mediation model. The nonmotor PD symptoms x social support interaction with stigma as the criterion variable was not
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significant (b = -.023, p = .501). When mental health was the criterion, the interaction between
non-motor PD symptoms x social support was not significant (b = .037, p = .146), while stigma x
social support was significant (b = -.050, p = .031; Figure 5).
Table 9. Model Summary for the Association between Non-Motor Symptoms and Mental Health
through Stigma by Social Support (N = 392).
95% Bias-corrected bootstrap
Social Support
Estimate (SE)
confidence interval
Model 1: DV = Stigma
Non-Motor Symptoms
.23(.05)***
.13 to .33
Social Support
-.30(.06)***
-.42 to -.18
Non-Motor Symptoms × Social Support
-.02(.03)
-.09 to .04
2
R
.24***
Model 2: DV = Mental Health
Non-Motor Symptoms
.34(.04)***
.27 to .41
Stigma
.13(.03)***
.06 to .20
Social Support
-.09(.04)*
-.17 to -.004
Non-Motor Symptoms × Social Support
.04(.03)
-.01 to .09
Stigma × Social Support
-.05(.02)*
-.10 to -.005
R2
.42***
Note. 5,000 bootstrap samples. DV = dependent variable. **p < .05. ***p < .001.
Figure 5
Moderation of stigma to mental health by levels of social support
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Follow-up analyses examined the indirect effect at different levels of the moderator
(social support; Table 10). While the indirect effect did not change by vacillating between

33

statistical significance and non-significance, the size of the indirect effect did decrease in the
hypothesized direction (H4).
Table 10. Conditional Indirect Effects of Non-Motor PD Symptoms on Mental Health at Levels
of Social Support (N = 392)
95% Bias-corrected
Social Support
Effect
Estimate (SE)
bootstrap confidence
interval
Low
.04*
.02
.01 to .09
High
.02*
.01
.001 to .05
Note. *Effects are considered statistically significant if the 95% bias-corrected bootstrap
confidence interval does not encapsulate zero.
Moderated mediation: Motor symptoms as predictor and spirituality as moderator.
In the third moderated mediation model, motor PD symptoms was specified to have a direct
effect on mental health, as well as an indirect effect through stigma, using 5,000 bootstrap
samples. The direct paths from motor PD symptoms to stigma (b = .427, p < .001) and from
stigma to mental health (b = .161, p < .001) were both statistically significant. Further, the direct
path from motor PD symptoms to mental health was statistically significant in the model (b =
.187, p < .001).
Next, it was examined whether the mediational effect from motor PD symptoms through
stigma to mental health problems differed as a function of participants’ level of spirituality. The
overall model predicting mental health was significant, F(5, 343) = 55.367, p < .001, R2 = .447.
Table 11 presents the b-weights, standard errors, p-values, and 95% bias-correct bootstrap
confidence intervals for each of the paths included in the moderated-mediation model. The motor
PD symptoms x spirituality interaction with stigma as the criterion variable was not significant (b
= -.08, p = .053). When mental health was the criterion, both the interactions between motor PD
symptoms x spirituality (b = .08, p = .019; Figure 6) and stigma x spirituality were significant (b
= -.07, p = .017; Figure 7). A regression was run to examine a potential effect of
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multicollinearity on the direction of the motor PD symptoms x spirituality moderation, as the
effect of high spirituality was not in the expected direction. While the overall model was
significant F(3, 345) = 75.290, p < .001, R2 = .396, the interaction was not (β =.037, p = .402).
This suggests again that the direction of the interaction is an artifact of multicollinearity in the
model devoid of meaning.
Table 11. Model Summary for the Association between Motor Symptoms and Mental Health through
Stigma by Spirituality (N = 349).
Estimate
95% Bias-corrected bootstrap
Spirituality
(SE)
confidence interval
Model 1: DV = Stigma
Motor Symptoms
.43(.05)***
.34 to .52
Spirituality
-.12(.05)**
-.21 to -.02
Motor Symptoms × Spirituality
-.08(.04)
-.17 to .001
R2
.27***
Model 2: DV = Mental Health
Motor Symptoms
.19(.03)***
.12 to .04
Stigma
.16(.04)***
.09 to .23
Spirituality
-.29(.03)***
-.36 to -.23
Motor Symptoms × Spirituality
.08(.03)**
.01 to .14
Stigma × Spirituality
-.07(.03)**
-.12 to -.01
R2
.45***
Note. 5,000 bootstrap samples. DV = dependent variable. **p < .05. ***p < .001.
Figure 6
Moderation of motor PD symptoms to mental health by levels of spirituality found to be an
artifact of multicollinearity
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Figure 7
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Moderation of stigma to mental health by levels of spirituality
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Follow-up analyses examined the conditional effects at different levels of the moderator
(spirituality). There were conditional direct and indirect effects of motor PD symptoms on
mental health by spirituality. Specifically, motor PD symptoms had a larger direct effect on
mental health problems for participants with high spirituality relative to those with low or mid
spirituality, suggesting an intensifying effect of spirituality on this direct effect inconsistent with
H5 but reflective of error and an artifact of multicollinearity devoid of meaning (Table 12).
Conversely, the indirect effect of motor PD symptoms on mental health problems through stigma
was stronger at lower levels of spirituality than at high levels, suggesting that this mediational
model only held for those with low and mid spirituality and therefore a buffering effect
consistent with H5 and supporting a moderated mediation (Table 13).
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Table 12. Conditional Direct Effects of Motor PD Symptoms on Mental Health at Levels of
Spirituality (N = 349)
95% Bias-corrected
Spirituality
Effect
Estimate (SE)
bootstrap confidence
interval
Low
.12*
.04
.04 to .20
Mid
.20*
.03
.13 to .26
High
.27*
.05
.17 to .37
Note. *Effects are considered statistically significant if the p value is < .05 and the 95% biascorrected bootstrap confidence interval does not encapsulate zero.
Table 13. Conditional Indirect Effects of Motor PD Symptoms on Mental Health at Levels of
Spirituality (N = 349)
95% Bias-corrected
Spirituality
Effect
Estimate (SE)
bootstrap confidence
interval
Low
.11*
.03
.04 to .18
Mid
.06*
.03
.02 to .12
High
.03
.03
-.02 to .10
Note. *Effects are considered statistically significant if the 95% bias-corrected bootstrap
confidence interval does not encapsulate zero.
Moderated mediation: Non-motor symptoms as predictor and spirituality as
moderator. In the fourth moderated mediation model, non-motor PD symptoms was specified to
have a direct effect on mental health, as well as an indirect effect through stigma, using 5,000
bootstrap samples. The direct paths from non-motor PD symptoms to stigma (b = .343, p < .001)
and from stigma to mental health (b = .151, p < .001) were both statistically significant. Further,
the direct path from non-motor PD symptoms to mental health was statistically significant in the
model (b = .281, p < .001).
Next, it was examined whether the mediational effect from non-motor PD symptoms
through stigma to mental health differed as a function of participants’ level of spirituality. The
overall model predicting mental health was significant, F(5, 343) = 70.002, p < .001, R2 = .505.
Table 14 presents the b-weights, standard errors, p-values, and 95% bias-correct bootstrap
confidence intervals for each of the paths included in the moderated-mediation model. The non37

motor PD symptoms x spirituality interaction with stigma as the criterion variable was not
significant (b = -.052, p = .174). When mental health was the criterion, the interaction between
non-motor PD symptoms x spirituality (b = -.002, p = .940) and stigma x spirituality were also
not significant (b = -.025, p = .346). These results indicate no pattern of interactions with
spirituality. Two regressions were run to examine a potential effect of multicollinearity (due to
two interaction terms being used in the same PROCESS model) on the interaction of nonmotor
PD symptoms x spirituality and stigma x spirituality. For nonmotor PD symptoms x spirituality,
the overall model was significant F(3, 345) = 30.098, p < .001, R2 = .464; however, the
interaction was not (β = -.039, p = .355). The same was true for stigma x spirituality, with the
overall model being significant F(3, 345) = 25.168, p < .001, R2 = .392, while the interaction was
not (β = -.055, p = .225). This supports the findings of the PROCESS model and suggests this
was not a result of multicollinearity in the model.
Table 14. Model Summary for the Association between Non-Motor Symptoms and Mental Health
through Stigma by Spirituality (N = 349).
95% Bias-corrected bootstrap confidence
Spirituality
Estimate (SE)
interval
Model 1: DV = Stigma
.34(.05)***
.24 to .44
Non-Motor Symptoms
Spirituality
-.12(.05)**
-.23 to -.02
Non-Motor Symptoms × Spirituality
-.05(.04)
-.13 to .02
R2
.44***
Model 2: DV = Mental Health
.28(.03)***
.22 to .34
Non-Motor Symptoms
.15(.03)***
.09 to .21
Stigma
Spirituality
-.24(.03)***
-.30 to -.18
Non-Motor Symptoms × Spirituality
-.002(.03)
-.05 to .05
Stigma × Spirituality
-.03(.03)
-.08 to .03
2
R
.51***
Note. 5,000 bootstrap samples. DV = dependent variable. **p < .05. ***p < .001.
Follow-up analyses examined the indirect effect at different levels of the moderator
(spirituality; Table 15). The indirect effect of non-motor PD symptoms on mental health
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problems through stigma was stronger at low and mid-levels of spiritualty than at high levels,
suggesting that this mediational model held only for those with low and mid-spirituality and
therefore a buffering effect consistent with H5.
Table 15. Conditional Indirect Effects of Non-Motor PD Symptoms on Mental Health at Levels
of Spirituality (N = 349)
95% Bias-corrected
Spirituality
Effect
Estimate (SE)
bootstrap confidence
interval
Low
.07*
.03
.02 to .12
Mid
.05*
.02
.01 to .10
High
.04
.03
-.003 to .10
Note. *Effects are considered statistically significant if the 95% bias-corrected bootstrap
confidence interval does not encapsulate zero.
Regressions. In order to identify the patterns of connections among PD symptoms,
stigma, and mental health, a series of hierarchical multiple regressions were performed using
SPSS Software Package, Version 26. In the first hierarchical multiple regression, age was
entered in the first step, motor and non-motor symptoms in the second, and stigma as the
outcome. The overall model was significant and explained 34.4% of variance in stigma [F(3,
388) = 67.77, p < .001, R2 = .344]. When considering each symptom type separately, only the
motor symptoms uniquely predicted stigma (β =.450, p < .001), while non-motor (β =.102, p =
.055) did not. Age was also a unique predictor (β = -.318, p < .001) of stigma.
In the second hierarchical multiple regression, age and education were entered in the first
step, motor and non-motor symptoms in the second, with apathy as the outcome. The overall
model was significant and explained 11.1% of variance in apathy [F(4, 386) = 12.01, p < .001,
R2 = .111]. When considering each symptom type separately, both the motor symptoms (β
=.176, p = .005) and non-motor (β =.153, p = .014) uniquely predicted apathy. Age (β = .063, p =
.201) and years of education (β = -.093, p = .059) were not unique predicators of apathy.
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In the third hierarchical multiple regression, age and education were entered in the first
step, motor and non-motor symptoms in the second, with stigma as the outcome. The overall
model was significant and explained 33.2% of variance in stigma [F(4, 386) = 47.92, p < .001,
R2 = .332]. When considering each symptom type separately, only the non-motor symptoms
uniquely predicted anxiety (β =.477, p < .001), while motor (β =.095, p = .082) did not. Age was
also a unique predictor (β = -.123, p = .004) of anxiety, while years of education (β = -.070, p =
.102) was not.
In the fourth hierarchical multiple regression, age and education were entered in the first
step, motor and non-motor symptoms in the second, with depression as the outcome. The overall
model was significant and explained 38.3% of variance in stigma [F(4, 386) = 59.96, p < .001,
R2 = .383]. When considering each symptom type separately, both the motor symptoms (β
=.152, p = .004) and non-motor (β =.465, p < .001) uniquely predicted depression. Age (β = .134, p = .001) and years of education (β = -.108, p = .008) were also was also unique predictors
of depression.
Discussion
As incidence of PD rises, so too does the need to examine the social consequences of PD.
Such consequences include increased experiences of stigma as a results of symptoms of PD
(Moore & Knowles, 2006). Individuals with PD who experience higher rates of stigma may
isolate and withdraw themselves as a result of negative and stigmatizing experiences (Burgener
& Berger, 2008), which may ultimately lead to poorer mental health outcomes (Hatzenbuehler et
al., 2013; Mak et al., 2007; Meyer, 2003; Pascoe & Smart Richman, 2009). Relatively little
research exists examining the potential mediation effect of stigma on the relationship between
symptoms and poor mental health or on the role of social support and spirituality as potential
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protective factors. This study sought to examine the connections among PD symptoms (motor
and non-motor), stigma, and mental health problems, as well as examine whether social support
and spirituality moderated these relationships.
Descriptives
Symptoms. In the current study, participants reported an average of nine motor
symptoms and nine non-motor symptoms. These motor and non-motor symptom averages were
composed of items from both the PDQ-39 and NMS, and therefore the rates cannot be compared
directly to other studies. However, the rate of non-motor symptoms was very similar to the
overall average reported by Martinez-Martin and colleagues (2007) of 10.25 non-motor
symptoms (SD = 5.3; range 0-28), with a range by country from a low of 9.28 (SD = 4.3) in Italy
and high of 12.71 (SD = 5.7) in Israel (Martinez‐Martin et al., 2007) of the six countries included
in the study. To the author’s knowledge, no similar assessment exists for motor symptoms.
Apathy. In the current study, 37.2% of the sample reported significant levels of apathy.
This rate is comparable with previous research which suggests apathy occurs for approximately
40% of individuals with PD (Brok et al., 2015) as well as in 20-36% of newly diagnosed
individuals (Pagonabarraga et al., 2015). As data were collected during participants’ first
neuropsychological evaluation, this comparison makes sense. It is, however, unknown whether
this first assessment was a patient’s first time being seen at the clinic having had a previous
diagnosis or if they were newly diagnosed patients. This distinction may be important as levels
of apathy vary across the disease course (Dujardin et al., 2007; Pluck & Brown, 2002; Wee et al.,
2016).
Anxiety. In the current study, of those who completed the BAI, 56.1% had at least mild
anxiety. Of those who completed the GAD-7, 34.8% had at least mild anxiety. While the GAD-7
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rates are in line with previous research, the BAI figures greatly exceeded the estimated rates of
25% to 40% of individuals with PD who will experience clinically significant anxiety (Kano et
al., 2011; Pontone et al., 2009; Quelhas & Costa, 2009; Starkstein, Robinson, Leiguarda, &
Preziosi, 1993; Walsh & Bennett, 2001). There are several possible reasons for the differences in
the performance of the BAI and GAD-7. These include the number of individuals administered
each measure (BAI N = 274; GAD-7 N = 158). Other reasons why the BAI may indicate higher
levels of anxiety include that anxiety is part of prodromal syndrome of PD (Chen et al., 2015;
Jacob et al., 2010) and many individuals may experience anxiety related to specific PD
symptoms (Coakeley et al., 2014; Dissanayaka et al., 2016; Martens et al., 2016). These may be
better captured by the items of the BAI than the GAD-7.
Depression. In the current study, of those who completed the BDI-II, 24% of individuals
had at least mild depression. Of those who completed the PHQ-9, 51% had at least mild
depression. Of those who completed the GDS-SF, 38.5% had at least mild depression, with no
participants scoring in the severe depression range. It is noteworthy that the GDS-SF did not
record severe depression compared to the BDI-II or the PHQ-9. There are several possible
explanations for this. The first is that the constructs being measured by the GDS-SF, BDI-II and
PHQ-9 may be slightly different. However, in a study comparing nine different depression scales
in PD patients, it was suggested that all nine performed equally well with the exception of the
Unified Parkinson's Disease Rating Scale for Depression (Williams et al., 2012). Furthermore,
the GDS-SF was only administered to those age 65 and above, so it may be that there may be
something significant about older PD patients or unique about this group of older PD patients.
Overall, those administered the PHQ-9 reported the highest levels of depression, followed by the
BDI-II, and the GDS-SF. The rates of depression indicated by the BDI-II were only slightly
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higher than other studies, while the PHQ-9 was significantly higher (Quelhas & Costa, 2009).
This again may be a result of differences in the measures or in the patients who were
administered the measures. There is also significantly more data from the BDI-II (N = 287) than
either the PHQ-9 (N = 155) or GDS-SF (N = 70), which may also account for some of the
differences. A possible explanation for why participants in the current study had higher selfreported rates of depression than previous studies is that the majority of the sample was male.
These individuals are potentially experiencing significant life changes, both due to age and
gender. For example, they may have been forced to recently retired, facing a different type of
retirement than previously envisioned, or facing an early retirement due to changing abilities.
This disruption caused by PD symptoms may pose a greater threat to a masculine self-identity
and contribute to depression (Oliffe et al., 2013; Reitzes et al., 1996; Solimeo, 2008).
Stigma. In the current study, participants reported an average of 16.20 (SD=21.20, range
0-100). This was lower than in other studies which means ranged from 34.67 to 48.13 (Jenkinson
et al., 1995; Martinez-Martin et al., 2007; Peto et al., 2001). There are many possible reasons for
this including this was a clinical sample from a specialized multidisciplinary PD clinic. Having
access to the clinic and these resources may suggest a less stigmatizing environment and
therefore the individuals feel and internalize less stigma (Ma et al., 2016). These individuals may
also have greater support in managing their PD identities, which may protect them from feeling
as stigmatized by it (Roger & Medved, 2010). Finally, these questions were asked within the
context of a clinical interview, so the individuals with PD had a relationship with a provider,
which may influence the responses they provide compared to other research methods, such as a
mailed survey (Peto et al., 1998).
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Social Support. In the current study, participants reported an average score of 90.10
(SD=17.03, range 8.33-100). This was notably higher than in other studies which means ranged
from 24.25 to 48.99 (Jenkinson et al., 1995; Martinez-Martin et al., 2007; Peto et al., 2001).
There are many possible explanations for this, including that this is a clinical sample which
likely requires support/caregivers (Martínez-Martín et al., 2007). Prior relationships may be
being redefined as individuals take on informal caregiving roles (Jeyathevan et al., 2019;
Roberto et al., 2019). By adding a caregiving role on top of an existing relationship, this may
increase the perception of social support in the context of the existing relationship. Furthermore,
the questions assessing social support focused on relationship problems and lack of support from
spouses, close relationships, family, and friends. Informal caregivers most often fall into one of
these categories. As such, informal caregiving may be enmeshed with other social relationships
in these responses, producing this high rate.
Spirituality. In the current study, participants reported an average spirituality score of
7.77 (SD=2.02, range 0-10). Compared to a group of hospitalized depressed older adults
responding to the same item (M = 6.57, SD = 2.61 at baseline; M = 7.86, SD = 1.76 at discharge),
the spirituality scores were on par (Piderman et al., 2011). This may be in part because
spirituality has been demonstrated to increase in older adulthood (MacKinlay, 2016) and has
been shown to be a common form of coping in clinical populations (Prizer et al., 2019; Roger &
Hatala, 2018).
Correlations. The results of the bivariate correlations mostly followed expected patterns.
Specifically, motor and non-motor symptoms were highly correlated. Further, for both symptom
types, as one experienced increasing numbers of symptoms one also experienced higher levels of
stigma and mental health issues. This may be because as individuals have increasing symptoms,
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they may experience greater difficulty caring for themselves and have higher levels of disability
(Ellis et al., 2016; Rana et al., 2017). In the extant literature, both difficulty caring for oneself
and greater disability may contribute to both higher rates of mental health issues and higher
levels of stigma (Ma et al., 2016; Maffoni et al., 2017; Thangavelu et al., 2020). For stigma, as
with previous literature, it was correlated with lower social support (Birtel et al., 2017; Ma et al.,
2016) and more mental health problems (Hatzenbuehler et al., 2013; Mak et al., 2007; Meyer,
2003; Pascoe & Smart Richman, 2009).
Social support and spirituality were each related to decreased mental health problems,
which supports previous literature (Harris et al., 2010; Reynolds, 2017; Simpson et al., 2006;
Takahashi et al., 2016). Among the demographics, age was associated with greater symptoms
and more social support (Petrou, Dwamena, Foerster, MacEachern, Bohnen, Muller, et al., 2015;
Shulman et al., 2016). While stereotypes suggest that older adults experience less social support
(Makita et al., 2019), the evidence is mixed regarding social support and aging (Cattan et al.,
2005; Dai et al., 2016; Weiner et al., 2016). However, because of informal caregiving needs of
this clinical PD population, this effect may be mitigated.
Education, sex, and age correlated with many of the study variables. Education was
associated with lower mental health problems which supports previous studies (Alegría et al.,
2000; Steele et al., 2007; Wang et al., 2000). Slight sex differences existed in the current study
such that females reported more non-motor symptoms. In previous studies, women have reported
greater symptoms for both physical (Lichtman et al., 2018; Styrke et al., 2013) and mental health
conditions (Newmann, 1984; Norris et al., 2001). While there may be sex differences in the
presentation of conditions, there are also gender-role differences in reporting and seeking help
for health conditions (Gast & Peak, 2011; Wyke et al., 1998). Contrary to previous studies
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(Antonucci & Akiyama, 1987; Caetano et al., 2013; White et al., 2009), males in the current
study reported significantly higher levels of social support. However, in a previous study with a
clinical population, males also reported higher social support (Berard et al., 2012). This suggests
populations with chronic or major health conditions may perceive or experience social support
differently. Additionally, in the current study, there was a greater proportion of males in the
study sample. Another possible explanation is that the onset of PD in men is approximately 2-2.1
years earlier than women (Gillies et al., 2014; Miller & Cronin-Golomb, 2010), which may lead
to needing caretaking sooner or more time for adaptation of one’s social network. No sex
differences existed in mental health problems in the current study, which is not supported in the
literature (Clancy & Gove, 1974; de Sá Junior et al., 2019) which may in part be due to the fact
that over half the sample was male. Interestingly, spirituality was not related to age, sex, or
education. Previous studies have found that older adults (MacKinlay, 2016) and women (Francis
& Wilcox, 1996; Kregting et al., 2019; Maselko & Kubzansky, 2006) are more likely to report
spirituality. Regarding education, individuals with less formal education are more likely to
identify as religious or religious and spiritual, with those with more formal education outpacing
other groups as identifying themselves as “spiritual, but not religious” (Lipka & Gecewicz,
2017). The distinction between spirituality and religiosity may have important clinical
implications in the future.
Mediational Analyses: Motor and Non-Motor Symptoms
Stigma partially mediated the relationship between both motor and non-motor symptoms
and mental health problems. These findings are consistent with prior research that suggests that
motor symptoms (Hermanns, 2013; Lyons et al., 1997; Maffoni et al., 2017) and non-motor
symptoms (Hemmesch et al., 2009; Jaywant & Pell, 2010; Tickle-Degnen et al., 2011) are
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related to stigma, and that stigma is related to mental health problems (Hatzenbuehler et al.,
2013; Mak et al., 2007; Meyer, 2003; Pascoe & Smart Richman, 2009). However, to the author’s
knowledge, there are no other studies which have tested these relationships in a mediation.
Moderated Mediations
Social support as a moderator of motor symptoms, stigma, and mental health.
Consistent with the study hypotheses, the present study documented a moderating effect of social
support on the relationships among motor symptoms, stigma, and mental health problems. The
indirect effect of motor PD symptoms on mental health problems through stigma was stronger at
lower levels of social support than at high levels, suggesting that this mediational model held
only for those with low social support and therefore a buffering effect. This is possibly because
individuals who have high support are shielded or better able to cope with stigma (Cadden et al.,
2018; Kondrat et al., 2018). Many individuals experience stigma as a threat, attack, or dismissal
of an identity (Herek et al., 20090126; Howarth, 2006). Having someone—a friend, a family
member, a significant other/partner, etc.—to talk and get advice from may allow an individual to
process the situation and increase perceptions of available coping resources (Stevens et al.,
2013). Specifically, social support provides individuals with an outlet to gain support, insight,
and ideas about stigmatizing encounters and to brainstorm new, effective ways of confronting
stigma (Chronister et al., 2013; Dudley, 2000). These findings are also supported theoretically by
the minority stress model (Meyer, 2003), which posits that distal minority stressors (e.g., stigma)
are associated with increased mental health problems. Additionally, the impact of distal stressors
on mental health may be mitigated by protective factors such as social support.
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Social support as a moderator of non-motor symptoms, stigma, and mental health.
Consistent with the study hypotheses, there was an indirect effect in the present study which
decreased in the hypothesized direction. However, the effect did not change between significant
and non-significant to suggest an overall moderating effect of social support on the relationships
among non-motor symptoms, stigma, and mental health problems. Furthermore, there was an
interaction of stigma x social support onto mental health problems, such that the buffering effect
was stronger for those at low levels of social support than high. Overall, those at high levels of
social support reported lower levels of mental health problems compared to those with low social
support. These findings are consistent with the pattern found for motor symptoms and suggest
that whether the experience of PD stigma is being driven by motor or non-motor PD symptoms,
social support is a potentially important protective factor.
Spirituality as a moderator of motor symptoms, stigma, and mental health.
Consistent with the study hypotheses, the present study documented a moderating effect of
spirituality on the relationships among motor symptoms, stigma, and mental health problems.
The indirect effect of motor PD symptoms on mental health problems through stigma was
stronger at lower levels of spirituality than at high levels, suggesting that this mediational model
only held for those with low and mid spirituality and therefore a buffering effect. A possible
explanation for this may be that aspects of spirituality are related to meaning making and
purpose (Doolittle & Farrell, 2004). As individuals experience increasing symptoms, it may
force them to confront the purpose or meaning of their illness and potentially reexamine
fundamental beliefs about themselves and the world (Egnew, 2018; Helgeson & Zajdel, 2017;
Shaw et al., 2005; Zeligman et al., 2018). With such a broad range of possible options imbedded
in the single spirituality question used in the present study, individuals could easily have
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interpreted this question to be consistent with their own form of spiritual coping (e.g., prayer,
meditation, healing circles, etc.; Klaassen et al., 2006; Narayanasamy, 2002; Siegel &
Schrimshaw, 2002).
There was also a significant interaction of stigma x spirituality predicting mental health,
such that increased spirituality reduced (buffered) the effect of stigma on mental health. Reasons
for this may include that at low and mid-levels of spirituality, as stigma increases, individuals
may be more prone to tap into the shame and blame narrative of chronic illness/disability (i.e.,
that their chronic illness/disability is a punishment or result of sin, or that they are being tested)
rather than finding meaning through benevolent reframing (i.e., karma or the will of God) and to
utilize support from a spiritual/religious community or leader (Clarke & Cardman, 2002;
Johnstone et al., 2007; Treloar, 2002). Gall and colleagues (2005) propose a theoretical
framework of spiritual coping. In this transactional model, individuals must appraise and
eventually make meaning out of a stressor, which ultimately influences their well-being (i.e.,
emotional, social, physical, and spiritual). This appraisal and meaning making process is
influenced by person factors, spiritual connections, and spiritual coping behaviors. Individuals
low in spirituality, but with greater stigma may be making greater personal attributions related to
their diagnosis, feel greater hopelessness about their situation, or have fewer spiritual coping
behaviors (Gall et al., 2005). These findings are also supported theoretically by the minority
stress model (Meyer, 2003), in which distal minority stressors (e.g., stigma) are associated with
increased mental health problems. Furthermore, the impact of distal stressors on mental health
may be buffered by protective factors such as spirituality.
Spirituality as a moderator of non-motor symptoms, stigma, and mental health.
Consistent with the study hypotheses, there was a moderating effect of spirituality on the
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relationships among non-motor symptoms, stigma, and mental health problems. Specifically, the
indirect effect of non-motor PD symptoms on mental health problems through stigma was
stronger at low and mid-levels of spiritualty than at high levels, suggesting that this mediational
model held only for those with low and mid-spirituality. The non-motor PD symptom findings
are consistent with the pattern found for motor symptoms and similarly suggest that whether the
experience of PD stigma is being driven by motor or non-motor PD symptoms, spirituality is a
potentially important protective factor.
While there was a moderating effect, there were no significant interactions such that any
of the individual paths were moderated by spirituality. One possible explanation for this is that a
single-item spirituality measure was used. With a single item it is not possible to measure
internal reliability. Further a single item generally has lower sensitivity and specificity,
suggesting a greater chance for error within this single-item measure. Finally, there is a question
of validity; whether a single item can capture the construct. The spirituality item used was rather
broad (i.e., regarding meaning/purpose, a higher power, etc.), which may have diffused the
meaning. However, as motor symptoms did have significant interactions and follow-up
regressions were also not significant, it is possible that for these individuals with PD an
interaction effect of spirituality is not present. This may suggest more potential benefits for target
intervention with individuals with certain motor PD symptoms—as opposed to non-motor PD
symptoms—particularly in regard to stigma.
Regressions. A series of multiple hierarchal regressions showed that age and motor
symptoms uniquely predicted stigma, motor and non-motor symptoms predicted apathy, nonmotor symptoms and age predicted anxiety, and motor symptoms, non-motor symptoms, age,
and education predicted depression. Age and motor symptoms predicting stigma supports prior
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research which suggests that it is the visible symptoms of PD that are most highly stigmatized
(Hermanns, 2013; Lyons et al., 1997; Maffoni et al., 2017). Age may be operating in a two-fold
manner in that these individuals are experiencing ageism and are more progressed in their
disease, thus likely to have more motor (visible) symptoms (Petrou, Dwamena, Foerster,
MacEachern, Bohnen, Muller, et al., 2015; Shulman et al., 2016).
For apathy, being predicted by both motor and non-motor symptoms may be the result of
the fact that goal directed, motivated behavior is more challenging in the face of greater
symptoms (Linde et al., 2017; Massimo et al., 2018). As it becomes increasingly difficult to
accomplish tasks, one may find it is harder to find the desire or motivation to do so. Regarding
depression, this finding supports previous literature that has clearly established a link between
age, education, and symptoms to depression (Brody et al., 2018; Katon & Ciechanowski, 2002;
Mirowsky & Ross, 1992; Palinkas et al., 1990). However, this study does so specifically within
the context of individuals with PD.
In the current study, non-motor symptoms and anxiety were related, although, anxiety is
often categorized as a non-motor symptom (Durcan et al., 2019; Pfeiffer, 2016). For the purpose
of this study, non-motor symptoms included things such as “Unexpectedly fallen asleep during
the day,” “Loss or change in your ability to taste or smell,” “Unexplained pain (not due to known
conditions such as arthritis” or “Seeing or hearing things that you know or are told are not there.”
For many, this loss of control (i.e., falling asleep, seeing/hearing things, and unexplained pain)
may be very unsettling and anxiety provoking. Further, symptoms of PD are not always constant
over time, and so individuals may be concerned about when and how bad a symptom experience
will be (Zhu et al., 2017).
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Potential Implications
The findings from the current study, guided by the minority stress model, provide insight
into the way PD symptoms are related to stigma and how that in turn influences mental health
outcomes. Furthermore, social support and spirituality may act as protective factors to mitigate
the relationships among PD symptoms, stigma, and mental health. From the current study, there
is a possibility to inform future targets for clinical interventions.
For example, as age and motor symptoms were found to uniquely predict stigma, this
may help to identify individuals with PD who may be at greater risk for stigmatization based
upon their clinical presentation and therefore may require targeted intervention. Additionally, as
stigma was found to mediate the relationship between both motor and non-motor PD symptoms
and mental health, health professionals working with individuals with PD may wish to consider
stigma and discrimination in how they present and design treatment options for PD patients. One
example of this may include connecting individuals with PD to support groups or mental health
services to process experiences of PD-related stigma.
There have been very few studies which have examined psychosocial treatments for
apathy, anxiety, and depression among individuals with PD. Acute management of anxiety and
depression using cognitive-behavioral therapy and other therapy modalities among individuals
with PD have demonstrated promise, although the long-term effects of these approaches have
had variable results (Yang et al., 2012). This may require further research to find the best
evidence-based practice to help facilitate disability identities and increase utilization of these
processes.
From these results, it will also be important to consider the role of social support, as it
was found to weaken the relationships among PD symptoms, stigma, and mental health. This
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suggests it may be important to find ways to increase and foster social support among individuals
with PD. In the current study, males reported higher levels of social support, which suggests it
may be of particular importance for clinicians working with female patients (and potentially
gender minority patients) to ensure they have access to a strong social support network. Social
support may come from a variety of places, including informal caregivers. However, for
individuals with PD, it may be important to have and maintain a number of positive close
relationships (Simpson et al., 2006). Additionally, considering both the type of support
individuals with PD receive (e.g., instrumental, emotional, and/or informational) and from whom
the support is received (e.g., family, friends, work colleagues, or health care professionals) is
vital, as this can have an influence on desired outcomes (Ravenek & Schneider, 2009).
Spirituality was also found, in the current study, to weaken the relationships among PD
symptoms, stigma, and mental health. Spiritual practices may buffer stress from chronic health
problems and increase quality of life (Delgado, 2007). Spirituality has also been demonstrated to
be a strong source of support for many individuals with chronic health problems (McNulty et al.,
2004; Narayanasamy, 2002). Including an assessment of spiritual practice and beliefs into patient
assessments may help health care providers better understand an individual with PD’s
worldview, and subsequently view of chronic illness, if there is a spiritual community of support,
and if spiritual interventions and coping mechanisms may be appropriate and helpful for the
individual (Nichols & Hunt, 2011).
Limitations and Future Directions
The current findings and potential implications should be viewed within the context of
the following limitations. First, this study was a secondary data analysis of PD patients from a
multidisciplinary PD clinic at a public, academic medical center in the Mid-Atlantic region. The
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sample was majority White, male, and had at least some college education. This sample may not
be generalizable, given the access to the specialty clinic and demographics. Also, as the
multidisciplinary PD clinic was located in a large urban center, this sample may not be
representative of individuals in more rural areas or those with more limited access to care. Future
studies may wish to collect data from a wider range of movement disorder clinics in both urban
and rural areas to have a more representative sample.
Second, the data were cross-sectional. As a result, causality cannot be established
regarding the time-ordered effect of greater PD symptoms leading to increased stigma and then
to more mental health problems. For example, in the PDQ-39 (which was used for motor PD
symptoms, non-motor PD symptoms, social support, and stigma) participants are asked to rate
how often something has occurred over the previous month (Peto et al., 1998). From this it
would not be possible to establish whether an experience of stigma occurred before or after the
presentation of a PD symptom. Future studies may wish to employ a longitudinal study design to
establish temporal order among the variables.
Third, there were several challenges in measurement that resulted from this secondary
data analysis. As it was a secondary dataset, no additional items or measures could be included.
In the current study, no spirituality demographic information was obtained. Future studies may
wish to survey individuals about their spiritual/religious affiliation to see if there are differences
across spiritual/religious orientations. There were also multiple measures for the same construct
(i.e., depression and anxiety). These measures were scored separately according to scoring
instructions, converted into z-scores, and then averaged. The motor and non-motor symptom
measures were composed of items from both the PDQ-39 and NMS—both self-report
measures—which were coded at the item level as either motor or non-motor using current PD
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criteria of motor and non-motor symptoms and clinician review. There was only a single-item
spirituality wellness measure. With only a single item, it is not possible to measure internal
reliability, there is lower sensitivity and specificity, and the validity of a single item is
questionable. Finally, the conceptualization and operationalization of stigma and social support
on the PDQ-39 is limiting. For stigma, the questions were more inwardly focused (i.e., “Felt you
had to conceal your Parkinson’s from people,” “Avoided situations which involve eating or
drinking in public,” or “Felt worried by other people’s reaction to you”). The social support
items were negatively valanced (i.e., “had problems” or “lacked support”), broad/vague (i.e.,
“support” and “problems”), and focused on a limited range of relationships (i.e., “close personal
relationships,” “spouse or partner,” or “family or close friends”). To address some of
measurement limitations of the present study, future studies may wish to use a physician
symptom rating scale such as The Movement Disorder Society-Sponsored Revision of the
Unified Parkinson’s Disease Rating Scale or the Hoehn and Yahr scale, a single mental health
measure for each construct, and additional spirituality, stigma, and social support measures.
Conclusions
The current study is among very few studies to examine the relationships among PD
symptoms (motor and non-motor), stigma, and mental health problems among individuals with
PD. Furthermore, it tested a mediational model linking these constructs among a clinical sample
of PD patients. The present study also examined a potential moderating effect of social support
and religiosity on the relationships among PD symptoms (motor and non-motor), stigma, and
mental health problems for individuals with PD.
For individuals with PD, social support buffered the relationships between motor
symptoms and mental health problems and stigma and mental health problems (in both models).
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Spirituality buffered the relationships between motor symptoms and mental health problems and
stigma and mental health problems (for motor symptoms only). Findings from this study suggest
that clinical intervention research with this population should focus on increasing social
support—with attention paid to sex differences—and opportunities for spiritual engagement
where appropriate. Furthermore, psychosocial treatments for apathy, anxiety, and depression
among individuals with PD should be examined to find the best evidence-based practices to help
facilitate disability identities and increase utilization of these processes. The current findings
suggest that social support and spirituality could potentially buffer mental health problems for
individuals with PD.

56

References
Adler, C. H., Beach, T. G., Zhang, N., Shill, H. A., Driver-Dunckley, E., Caviness, J. N., Mehta,
S. H., Sabbagh, M. N., Serrano, G. E., Sue, L. I., Belden, C. M., Powell, J., Jacobson, S.
A., Zamrini, E., Shprecher, D., Davis, K. J., Dugger, B. N., & Hentz, J. G. (2019).
Unified staging system for lewy body disorders: Clinicopathologic correlations and
comparison to Braak staging. Journal of Neuropathology & Experimental Neurology,
78(10), 891–899. https://doi.org/10.1093/jnen/nlz080
AlDakheel, A., Kalia, L. V., & Lang, A. E. (2014). Pathogenesis-targeted, disease-modifying
therapies in Parkinson disease. Neurotherapeutics, 11(1), 6–23.
https://doi.org/10.1007/s13311-013-0218-1
Alegría, M., Bijl, R., Lin, E., Walters, E., & Kessler, R. (2000). Income differences in persons
seeking outpatient treatment for mental disorders: A comparison of the United States with
Ontario and the Netherlands. Archives of General Psychiatry, 57(4), 383–391.
Antonucci, T. C., & Akiyama, H. (1987). An examination of sex differences in social support
among older men and women. Sex Roles: A Journal of Research, 17(11–12), 737–749.
https://doi.org/10.1007/BF00287685
Ball, N., Teo, W.-P., Chandra, S., & Chapman, J. (2019). Parkinson’s Disease and the
environment. Frontiers in Neurology, 10, 218. https://doi.org/10.3389/fneur.2019.00218
Beck, A. T., Steer, R. A., & Brown, G. K. (1996). Beck Depression Inventory manual (2nd ed).
Psychological Corporation.
Beck, Aaron T., Epstein, N., Brown, G., & Steer, R. A. (1988). An inventory for measuring
clinical anxiety: Psychometric properties. Journal of Consulting and Clinical Psychology,
56(6), 893–897. https://doi.org/10.1037/0022-006X.56.6.893

57

Berard, D. M., VanDenKerkhof, E. G., Harrison, M., & Tranmer, J. E. (2012). Gender
differences in the influence of social support on one-year changes in functional status in
older patients with heart failure. Cardiology Research and Practice, 2012.
https://doi.org/10.1155/2012/616372
Beyer, M. K., Herlofson, K., Arsland, D., & Larsen, J. P. (2001). Causes of death in a
community-based study of Parkinson’s disease. Acta Neurologica Scandinavica, 103(1),
7–11. https://doi.org/10.1034/j.1600-0404.2001.00191.x
Birtel, M. D., Wood, L., & Kempa, N. J. (2017). Stigma and social support in substance abuse:
Implications for mental health and well-being. Psychiatry Research, 252, 1–8.
https://doi.org/10.1016/j.psychres.2017.01.097
Bockting, W. O., Miner, M. H., Romine, R. E. S., Hamilton, A., & Coleman, E. (2013). Stigma,
mental health, and resilience in an online sample of the US transgender population.
American Journal of Public Health, 103(5), 943–951.
https://doi.org/10.2105/AJPH.2013.301241
Bogart, K. R. (2011). Is apathy a valid and meaningful symptom or syndrome in Parkinson’s
disease? A critical review. Health Psychology, 30(4), 386–400.
https://doi.org/10.1037/a0022851
Brewster, M. E., Velez, B. L., Foster, A., Esposito, J., & Robinson, M. A. (2016). Minority stress
and the moderating role of religious coping among religious and spiritual sexual minority
individuals. Journal of Counseling Psychology, 63(1), 119–126.
https://doi.org/10.1037/cou0000121

58

Brod, M., Mendelsohn, G. A., & Roberts, B. (1998). Patients’ experiences of Parkinson’s
disease. The Journals of Gerontology, 53(4), P213–P222.
https://doi.org/10.1093/geronb/53B.4.P213
Brody, D. J., Pratt, L. A., & Hughes, J. P. (2018, February). Prevalence of Depression Among
Adults Aged 20 and Over: United States, 2013–2016. Centers for Disease Control and
Prevention. https://www.cdc.gov/nchs/products/databriefs/db303.htm
Brok, M. G. H. E. den, Dalen, J. W. van, Gool, W. A. van, Charante, E. P. M. van, Bie, R. M. A.
de, & Richard, E. (2015). Apathy in Parkinson’s disease: A systematic review and metaanalysis. Movement Disorders, 30(6), 759–769. https://doi.org/10.1002/mds.26208
Bugalho, P., Ladeira, F., Barbosa, R., Marto, J. P., Borbinha, C., Salavisa, M., da Conceição, L.,
Saraiva, M., Fernandes, M., & Meira, B. (2019). Motor and non-motor function
predictors of mortality in Parkinson’s disease. Journal of Neural Transmission.
https://doi.org/10.1007/s00702-019-02055-3
Burgener, S. C., & Berger, B. (2008). Measuring perceived stigma in persons with progressive
neurological disease: Alzheimer’s dementia and Parkinson’s disease. Dementia, 7(1), 31–
53. https://doi.org/10.1177/1471301207085366
Cacabelos, R. (2017). Parkinson’s Disease: From Pathogenesis to Pharmacogenomics.
International Journal of Molecular Sciences, 18(3), 551.
https://doi.org/10.3390/ijms18030551
Cadden, M. H., Arnett, P. A., Tyry, T. M., & Cook, J. E. (2018). Judgment hurts: The
psychological consequences of experiencing stigma in multiple sclerosis. Social Science
& Medicine, 208, 158–164. https://doi.org/10.1016/j.socscimed.2018.01.015

59

Caetano, S. C., Silva, C. M., & Vettore, M. V. (2013). Gender differences in the association of
perceived social support and social network with self-rated health status among older
adults: A population-based study in Brazil. BMC Geriatrics, 13(1), 122.
https://doi.org/10.1186/1471-2318-13-122
Cattan, M., White, M., Bond, J., & Learmouth, A. (2005). Preventing social isolation and
loneliness among older people: A systematic review of health promotion interventions.
Ageing & Society, 25(1), 41–67. https://doi.org/10.1017/S0144686X04002594
Caviness, J. N. (2014). Pathophysiology of Parkinson’s disease behavior – a view from the
network. Parkinsonism & Related Disorders, 20, S39–S43.
https://doi.org/10.1016/S1353-8020(13)70012-9
Chapuis, S., Ouchchane, L., Metz, O., Gerbaud, L., & Durif, F. (2004). Impact of the motor
complications of Parkinson’s disease on the quality of life. Movement Disorders, 20(2),
224–230. https://doi.org/10.1002/mds.20279
Chaudhuri, K. R., Martinez‐Martin, P., Brown, R. G., Sethi, K., Stocchi, F., Odin, P., Ondo, W.,
Abe, K., MacPhee, G., MacMahon, D., Barone, P., Rabey, M., Forbes, A., Breen, K.,
Tluk, S., Naidu, Y., Olanow, W., Williams, A. J., Thomas, S., … Schapira, A. H. V.
(2007). The metric properties of a novel non-motor symptoms scale for Parkinson’s
disease: Results from an international pilot study. Movement Disorders, 22(13), 1901–
1911. https://doi.org/10.1002/mds.21596
Chen, H., Zhao, E. J., Zhang, W., Lu, Y., Liu, R., Huang, X., Ciesielski-Jones, A. J., Justice, M.
A., Cousins, D. S., & Peddada, S. (2015). Meta-analyses on prevalence of selected
Parkinson’s nonmotor symptoms before and after diagnosis. Translational
Neurodegeneration, 4(1). https://doi.org/10.1186/2047-9158-4-1

60

Chronister, J., Chou, C., & Liao, H. (2013). The role of stigma coping and social support in
mediating the effect of societal stigma on internalized stigma, mental health recovery,
and quality of life among people with serious mental illness. Journal of Community
Psychology, 41(5), 582–600. https://doi.org/10.1002/jcop.21558
Clancy, K., & Gove, W. (1974). Sex differences in mental illness: An analysis of response bias
in self-reports. American Journal of Sociology, 80(1), 205–216.
https://doi.org/10.1086/225767
Clarke, K. M., & Cardman, F. (2002). Spiritual resilience in people who live well with lifelong
disability. Journal of Religion, Disability & Health, 6(1), 23–36.
https://doi.org/10.1300/J095v06n01_03
Coakeley, S., Martens, K. E., & Almeida, Q. J. (2014). Management of anxiety and motor
symptoms in Parkinson’s disease. Expert Review of Neurotherapeutics, 14(8), 937–946.
Cohen, J., Cohen, P., West, S. G., & Aiken, L. S. (2003). Applied multiple regression/correlation
analysis for the behavioral sciences, 3rd ed. Lawrence Erlbaum Associates Publishers.
Collier, T. J., Kanaan, N. M., & Kordower, J. H. (2017). Aging and Parkinson’s Disease:
Different sides of the same coin? Movement Disorders, 32(7), 983–990.
https://doi.org/10.1002/mds.27037
Connolly, B. S., & Lang, A. E. (2014). Pharmacological treatment of Parkinson disease: A
review. JAMA, 311(16), 1670–1683. https://doi.org/10.1001/jama.2014.3654
Conover, K. J., & Israel, T. (2019). Microaggressions and social support among sexual
minorities with physical disabilities. Rehabilitation Psychology, 64(2), 167–178.
https://doi.org/10.1037/rep0000250

61

Dai, Y., Zhang, C.-Y., Zhang, B.-Q., Li, Z., Jiang, C., & Huang, H.-L. (2016). Social support and
the self-rated health of older people. Medicine, 95(24).
https://doi.org/10.1097/MD.0000000000003881
de Lau, L. M. L., & Breteler, M. M. B. (2006). Epidemiology of Parkinson’s disease. The
Lancet. Neurology, 5(6), 525–535. https://doi.org/10.1016/S1474-4422(06)70471-9
de Sá Junior, A. R., Liebel, G., Andrade, A. G. de, Andrade, L. H., Gorenstein, C., & Wang, Y.P. (2019). Can gender and age impact on response pattern of depressive symptoms
among college students? A differential item functioning analysis. Frontiers in Psychiatry,
10. https://doi.org/10.3389/fpsyt.2019.00050
Delgado, C. (2007). Sense of coherence, spirituality, stress and quality of life in chronic illness.
Journal of Nursing Scholarship, 39(3), 229–234. https://doi.org/10.1111/j.15475069.2007.00173.x
Dissanayaka, N. N. W., O’Sullivan, J. D., Pachana, N. A., Marsh, R., Silburn, P. A., White, E.
X., Torbey, E., Mellick, G. D., Copland, D. A., & Byrne, G. J. (2016). Disease-specific
anxiety symptomatology in Parkinson’s disease. International Psychogeriatrics, 28(7),
1153–1163. https://doi.org/10.1017/S1041610215002410
Doolittle, B. R., & Farrell, M. (2004). The association between spirituality and depression in an
urban clinic. Primary Care Companion to The Journal of Clinical Psychiatry, 6(3), 114–
118.
Dorsey, E. R., & Bloem, B. R. (2018). The Parkinson pandemic—A call to action. JAMA
Neurology, 75(1), 9–10. https://doi.org/10.1001/jamaneurol.2017.3299

62

Dozois, D. J. A., Dobson, K. S., & Ahnberg, J. L. (1998). A psychometric evaluation of the Beck
Depression Inventory–II. Psychological Assessment, 10(2), 83–89.
https://doi.org/10.1037/1040-3590.10.2.83
Dudley, J. R. (2000). Confronting stigma within the services system. Social Work, 45(5), 449–
455. https://doi.org/10.1093/sw/45.5.449
Dujardin, K., Sockeel, P., Devos, D., Delliaux, M., Krystkowiak, P., Destee, A., & Defebvre, L.
(2007). Characteristics of apathy in Parkinson’s disease. Movement Disorders, 22(6),
778–784. https://doi.org/10.1002/mds.21316
Durcan, R., Wiblin, L., Lawson, R. A., Khoo, T. K., Yarnall, A. J., Duncan, G. W., Brooks, D. J.,
Pavese, N., & Burn, D. J. (2019). Prevalence and duration of non-motor symptoms in
prodromal Parkinson’s disease. European Journal of Neurology, 26(7), 979–985.
https://doi.org/10.1111/ene.13919
Egnew, T. R. (2018). A narrative approach to healing chronic illness. Annals of Family
Medicine, 16(2), 160–165. https://doi.org/10.1370/afm.2182
Ehgoetz Martens, K. A., & Lewis, S. J. G. (2017). Pathology of behavior in PD: What is known
and what is not? Journal of the Neurological Sciences, 374, 9–16.
https://doi.org/10.1016/j.jns.2016.12.062
Elbaz, A., Bower, J. H., Peterson, B. J., Maraganore, D. M., McDonnell, S. K., Ahlskog, J. E.,
Schaid, D. J., & Rocca, W. A. (2003). Survival study of Parkinson disease in Olmsted
County, Minnesota. Archives of Neurology, 60(1), 91–96.
https://doi.org/10.1001/archneur.60.1.91
Ellis, T. D., Cavanaugh, J. T., Earhart, G. M., Ford, M. P., Foreman, K. B., Thackeray, A.,
Thiese, M. S., & Dibble, L. E. (2016). Identifying clinical measures that most accurately

63

reflect the progression of disability in Parkinson disease. Parkinsonism & Related
Disorders, 25, 65–71. https://doi.org/10.1016/j.parkreldis.2016.02.006
Ertan, F., Ertan, T., Kiziltan, G., & Uygucgil, H. (2005). Reliability and validity of the Geriatric
Depression Scale in depression in Parkinson’s disease. Journal of Neurology,
Neurosurgery, and Psychiatry, 76(10), 1445–1447.
https://doi.org/10.1136/jnnp.2004.057984
Evans, J. R., Mason, S. L., Williams-Gray, C. H., Foltynie, T., Brayne, C., Robbins, T. W., &
Barker, R. A. (2011). The natural history of treated Parkinson’s disease in an incident,
community based cohort. Journal of Neurology, Neurosurgery, and Psychiatry, 82(10),
1112–1118. https://doi.org/10.1136/jnnp.2011.240366
Faul, F., Erdfelder, E., Lang, A.-G., & Buchner, A. (2007). G*Power 3: A flexible statistical
power analysis program for the social, behavioral, and biomedical sciences. Behavior
Research Methods, 39(2), 175–191.
Fereshtehnejad, S.-M., Shafieesabet, M., Shahidi, G. A., Delbari, A., & Lökk, J. (2015). Restless
legs syndrome in patients with Parkinson’s disease: A comparative study on prevalence,
clinical characteristics, quality of life and nutritional status. Acta Neurologica
Scandinavica, 131(4), 211–218. https://doi.org/10.1111/ane.12307
Ferreira, J. J., Katzenschlager, R., Bloem, B. R., Bonuccelli, U., Burn, D., Deuschl, G., Dietrichs,
E., Fabbrini, G., Friedman, A., Kanovsky, P., Kostic, V., Nieuwboer, A., Odin, P.,
Poewe, W., Rascol, O., Sampaio, C., Schüpbach, M., Tolosa, E., Trenkwalder, C., …
Oertel, W. H. (2013). Summary of the recommendations of the EFNS/MDS-ES review
on therapeutic management of Parkinson’s disease. European Journal of Neurology,
20(1), 5–15. https://doi.org/10.1111/j.1468-1331.2012.03866.x

64

Fitzpatrick, R., Peto, V., Jenkinson, C., Greenhall, R., & Hyman, N. (1997). Health-related
quality of life in Parkinson’s disease: A study of outpatient clinic attenders. Movement
Disorders, 12(6), 916–922. https://doi.org/10.1002/mds.870120613
Fitzpatrick, Ray, Newman, S., Lamb, R., & Shipley, M. (1988). Social relationships and
psychological well-being in rheumatoid arthritis. Social Science & Medicine, 27(4), 399–
403. https://doi.org/10.1016/0277-9536(88)90275-4
Fleminger, S. (1991). Left-sided Parkinson’s disease is associated with greater anxiety and
depression. Psychological Medicine, 21(3), 629–638.
https://doi.org/10.1017/S0033291700022261
Forsaa, E. B., Larsen, J. P., Wentzel-Larsen, T., & Alves, G. (2015). A 12-year population-based
study of freezing of gait in Parkinson’s disease. Parkinsonism & Related Disorders,
21(3), 254–258. https://doi.org/10.1016/j.parkreldis.2014.12.020
Fox, S. H., Katzenschlager, R., Lim, S.-Y., Ravina, B., Seppi, K., Coelho, M., Poewe, W.,
Rascol, O., Goetz, C. G., & Sampaio, C. (2011). The Movement Disorder Society
evidence-based medicine review update: Treatments for the motor symptoms of
Parkinson’s disease. Movement Disorders, 26 Suppl 3, S2-41.
https://doi.org/10.1002/mds.23829
Francis, L. J., & Wilcox, C. (1996). Religion and gender orientation. Personality and Individual
Differences, 20(1), 119–121. https://doi.org/10.1016/0191-8869(95)00135-S
Gall, T. L., Charbonneau, C., Clarke, N. H., Grant, K., Joseph, A., & Shouldice, L. (2005).
Understanding the nature and role of spirituality in relation to coping and health: A
conceptual framework. Canadian Psychology/Psychologie Canadienne, 46(2), 88–104.
https://doi.org/10.1037/h0087008

65

Gast, J., & Peak, T. (2011). “It used to be that if it weren’t broken and bleeding profusely, I
would never go to the doctor”: Men, masculinity, and health. American Journal of Men’s
Health, 5(4), 318–331. https://doi.org/10.1177/1557988310377926
Gibb, W. R., & Lees, A. J. (1988). The relevance of the Lewy body to the pathogenesis of
idiopathic Parkinson’s disease. Journal of Neurology, Neurosurgery, and Psychiatry,
51(6), 745–752.
Gillies, G. E., Pienaar, I. S., Vohra, S., & Qamhawi, Z. (2014). Sex differences in Parkinson’s
disease. Frontiers in Neuroendocrinology, 35(3), 370–384.
https://doi.org/10.1016/j.yfrne.2014.02.002
Goetz, C. G., Poewe, W., Rascol, O., Sampaio, C., Stebbins, G. T., Counsell, C., Giladi, N.,
Holloway, R. G., Moore, C. G., Wenning, G. K., Yahr, M. D., & Seidl, L. (2004).
Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale:
Status and recommendations The Movement Disorder Society Task Force on rating
scales for Parkinson’s disease. Movement Disorders, 19(9), 1020–1028.
https://doi.org/10.1002/mds.20213
Goetz, C. G., Tilley, B. C., Shaftman, S. R., Stebbins, G. T., Fahn, S., Martinez-Martin, P.,
Poewe, W., Sampaio, C., Stern, M. B., Dodel, R., Dubois, B., Holloway, R., Jankovic, J.,
Kulisevsky, J., Lang, A. E., Lees, A., Leurgans, S., LeWitt, P. A., Nyenhuis, D., …
LaPelle, N. (2008). Movement Disorder Society-sponsored revision of the Unified
Parkinson’s Disease Rating Scale (MDS-UPDRS): Scale presentation and clinimetric
testing results. Movement Disorders, 23(15), 2129–2170.
https://doi.org/10.1002/mds.22340
Goffman, E. (1963). Stigma: Notes on the Management of Spoiled Identity. Simon and Schuster.

66

Gunnery, S. D., Saint-Hilaire, M.-H., Thomas, C., & Tickle-Degnen, L. (2015). Emerging
Evidence for Facial Muscle Action as a Predictor of Experienced Stigma in Parkinson’s
Disease. Archives of Physical Medicine and Rehabilitation, 96(10), e74.
https://doi.org/10.1016/j.apmr.2015.08.251
Harris, S. T., Wong, D., & Musick, D. (2010). Spirituality and well-being among persons with
diabetes and other chronic disabling conditions: A comprehensive review. Journal of
Complementary and Integrative Medicine, 7(1), 1553–3840.
Hatzenbuehler, M. L., Phelan, J. C., & Link, B. G. (2013). Stigma as a fundamental cause of
population health inequalities. American Journal of Public Health, 103(5), 813–821.
https://doi.org/10.2105/AJPH.2012.301069
Hayes, A. F. (2017). Introduction to mediation, moderation, and conditional process analysis: A
regression-based approach (Second Edition). The Guilford Press.
https://www.guilford.com/books/Introduction-to-Mediation-Moderation-and-ConditionalProcess-Analysis/Andrew-Hayes/9781462534654
Helgeson, V. S., & Zajdel, M. (2017). Adjusting to chronic health conditions. Annual Review of
Psychology, 68(1), 545–571. https://doi.org/10.1146/annurev-psych-010416-044014
Hemmesch, A. R. (2014). The detrimental effects of atypical nonverbal behavior on older adults’
first impressions of individuals with Parkinson’s disease. Psychology and Aging, 29(3),
521–527. https://doi.org/10.1037/a0036637
Hemmesch, A. R., Tickle-Degnen, L., & Zebrowitz, L. A. (2009). The influence of facial
masking and sex on older adults’ impressions of individuals with Parkinson’s disease.
Psychology and Aging, 24(3), 542–549. https://doi.org/10.1037/a0016105

67

Herek, G. M., Gillis, J. R., & Cogan, J. C. (20090126). Internalized stigma among sexual
minority adults: Insights from a social psychological perspective. Journal of Counseling
Psychology, 56(1), 32. https://doi.org/10.1037/a0014672
Hermanns, M. (2013). The invisible and visible stigmatization of Parkinson’s disease. Journal of
the American Association of Nurse Practitioners, 25(10), 563–566.
https://doi.org/10.1111/1745-7599.12008
Hoehn, M. M., & Yahr, M. D. (1967). Parkinsonism: Onset, progression and mortality.
Neurology, 17(5), 427–442. https://doi.org/10.1212/wnl.17.5.427
Howarth, C. (2006). Race as stigma: Positioning the stigmatized as agents, not objects. Journal
of Community & Applied Social Psychology, 16(6), 442–451.
https://doi.org/10.1002/casp.898
Hughes, A. J., Daniel, S. E., Kilford, L., & Lees, A. J. (1992). Accuracy of clinical diagnosis of
idiopathic Parkinson’s disease: A clinico-pathological study of 100 cases. Journal of
Neurology, Neurosurgery, and Psychiatry, 55(3), 181–184.
Hughes, S. L., Giobbie-Hurder, A., Weaver, F. M., Kubal, J. D., & Henderson, W. (1999).
Relationship between caregiver burden and health-related quality of life. The
Gerontologist, 39(5), 534–545. https://doi.org/10.1093/geront/39.5.534
Ishihara, L. S., Cheesbrough, A., Brayne, C., & Schrag, A. (2007). Estimated life expectancy of
Parkinson’s patients compared with the UK population. Journal of Neurology,
Neurosurgery, and Psychiatry, 78(12), 1304–1309.
https://doi.org/10.1136/jnnp.2006.100107
Ives, N. J., Stowe, R. L., Marro, J., Counsell, C., Macleod, A., Clarke, C. E., Gray, R., &
Wheatley, K. (2004). Monoamine oxidase type B inhibitors in early Parkinson’s disease:

68

Meta-analysis of 17 randomised trials involving 3525 patients. BMJ : British Medical
Journal, 329(7466), 593. https://doi.org/10.1136/bmj.38184.606169.AE
Jacob, E. L., Gatto, N. M., Thompson, A., Bordelon, Y., & Ritz, B. (2010). Occurrence of
depression and anxiety prior to Parkinson’s disease. Parkinsonism & Related Disorders,
16(9), 576–581. https://doi.org/10.1016/j.parkreldis.2010.06.014
Jankovic, J. (2008). Parkinson’s disease: Clinical features and diagnosis. Journal of Neurology,
Neurosurgery & Psychiatry, 79(4), 368–376. https://doi.org/10.1136/jnnp.2007.131045
Jaywant, A., & Pell, M. D. (2010). Listener impressions of speakers with Parkinson’s disease.
Journal of the International Neuropsychological Society, 16(1), 49–57.
https://doi.org/10.1017/S1355617709990919
Jenkinson, C., Peto, V., Fitzpatrick, R., Greenhall, R., & Hyman, N. (1995). Self-reported
functioning and well-being in patients with Parkinson’s disease: Comparison of the shortform health survey (SF-36) and the Parkinson’s Disease Questionnaire (PDQ-39). Age
and Ageing, 24(6), 505–509. https://doi.org/10.1093/ageing/24.6.505
Jeyathevan, G., Cameron, J. I., Craven, B. C., Munce, S. E. P., & Jaglal, S. B. (2019). Rebuilding relationships after a spinal cord injury: Experiences of family caregivers and
care recipients. BMC Neurology, 19(1), 117. https://doi.org/10.1186/s12883-019-1347-x
Johnstone, B., Glass, B. A., & Oliver, R. E. (2007). Religion and disability: Clinical, research
and training considerations for rehabilitation professionals. Disability and Rehabilitation,
29(15), 1153–1163. https://doi.org/10.1080/09638280600955693
Kano, O., Ikeda, K., Cridebring, D., Takazawa, T., Yoshii, Y., & Iwasaki, Y. (2011).
Neurobiology of depression and anxiety in Parkinson’s Disease. Parkinson’s Disease,
2011. https://doi.org/10.4061/2011/143547

69

Katon, W., & Ciechanowski, P. (2002). Impact of major depression on chronic medical illness.
Journal of Psychosomatic Research, 53(4), 859–863. https://doi.org/10.1016/S00223999(02)00313-6
Klaassen, D. W., McDonald, M. J., & James, S. (2006). Advance in the study of religious and
spiritual coping. In P. T. P. Wong & L. C. J. Wong (Eds.), Handbook of Multicultural
Perspectives on Stress and Coping (pp. 105–132). Springer US.
https://doi.org/10.1007/0-387-26238-5_6
Kondrat, D. C., Sullivan, W. P., Wilkins, B., Barrett, B. J., & Beerbower, E. (2018). The
mediating effect of social support on the relationship between the impact of experienced
stigma and mental health. Stigma and Health, 3(4), 305–314.
https://doi.org/10.1037/sah0000103
Korczyn, A. D., & Hassin-Baer, S. (2015). Can the disease course in Parkinson’s disease be
slowed? BMC Medicine, 13, 295. https://doi.org/10.1186/s12916-015-0534-x
Kregting, J., Scheepers, P., Vermeer, P., & Hermans, C. (2019). Why Dutch women are still
more religious than Dutch men: Explaining the persistent religious gender gap in the
Netherlands using a multifactorial approach. Review of Religious Research, 61(2), 81–
108. https://doi.org/10.1007/s13644-019-00364-3
Kroenke, K., Spitzer, R. L., & Williams, J. B. (2001). The PHQ-9: Validity of a brief depression
severity measure. Journal of General Internal Medicine, 16(9), 606–613.
Lee, A., & Gilbert, R. M. (2016). Epidemiology of Parkinson Disease. Neurologic Clinics, 34(4),
955–965. https://doi.org/10.1016/j.ncl.2016.06.012
Lees, A. J., Hardy, J., & Revesz, T. (2009). Parkinson’s disease. The Lancet, 373(9680), 2055–
2066. https://doi.org/10.1016/S0140-6736(09)60492-X

70

Lichtman, J. H., Leifheit, E. C., Safdar, B., Bao, H., Krumholz, H. M., Lorenze, N. P.,
Daneshvar, M., Spertus, J. A., & D’Onofrio, G. (2018). Sex differences in the
presentation and perception of symptoms among young patients with myocardial
infarction: Evidence from the VIRGO study (variation in recovery: Role of gender on
outcomes of young AMI patients). Circulation, 137(8), 781–790.
https://doi.org/10.1161/CIRCULATIONAHA.117.031650
Linde, R. M. van der, Matthews, F. E., Dening, T., & Brayne, C. (2017). Patterns and persistence
of behavioural and psychological symptoms in those with cognitive impairment: The
importance of apathy. International Journal of Geriatric Psychiatry, 32(3), 306–315.
https://doi.org/10.1002/gps.4464
Lipka, M., & Gecewicz, C. (2017, September 6). More Americans now say they’re spiritual but
not religious. Pew Research Center. https://www.pewresearch.org/facttank/2017/09/06/more-americans-now-say-theyre-spiritual-but-not-religious/
Litvan, I., MacIntyre, A., Goetz, C. G., Wenning, G. K., Jellinger, K., Verny, M., Bartko, J. J.,
Jankovic, J., McKee, A., Brandel, J. P., Chaudhuri, K. R., Lai, E. C., D’Olhaberriague,
L., Pearce, R. K., & Agid, Y. (1998). Accuracy of the clinical diagnoses of Lewy body
disease, Parkinson disease, and dementia with Lewy bodies: A clinicopathologic study.
Archives of Neurology, 55(7), 969–978. https://doi.org/10.1001/archneur.55.7.969
Locke, D. E. C., Decker, P. A., Sloan, J. A., Brown, P. D., Malec, J. F., Clark, M. M., Rummans,
T. A., Ballman, K. V., Schaefer, P. L., & Buckner, J. C. (2007). Validation of single-item
linear analog scale assessment of quality of life in neuro-oncology patients. Journal of
Pain and Symptom Management, 34(6), 628–638.
https://doi.org/10.1016/j.jpainsymman.2007.01.016

71

Lyons, K. E., Pahwa, R., Troster, A. I., & Koller, W. C. (1997). A comparison of Parkinson’s
disease symptoms and self-reported functioning and well being. Parkinsonism & Related
Disorders, 3(4), 207–209. https://doi.org/10.1016/S1353-8020(97)00021-7
Ma, H.-I., Saint-Hilaire, M., Thomas, C. A., & Tickle-Degnen, L. (2016). Stigma as a key
determinant of health-related quality of life in Parkinson’s disease. Quality of Life
Research, 25(12), 3037–3045. https://doi.org/10.1007/s11136-016-1329-z
MacCarthy, B., & Brown, R. (1989). Psychosocial factors in Parkinson’s disease. British Journal
of Clinical Psychology, 28(1), 41–52. https://doi.org/10.1111/j.20448260.1989.tb00810.x
MacKinlay, E. (2016). Ageing and spirituality across faiths and cultures. In M. Johnson & J.
Walker (Eds.), Spiritual Dimensions of Ageing (pp. 32–50). Cambridge University Press.
Maffoni, M., Giardini, A., Pierobon, A., Ferrazzoli, D., & Frazzitta, G. (2017). Stigma
Experienced by Parkinson’s Disease Patients: A Descriptive Review of Qualitative
Studies. Parkinson’s Disease, 2017, 7203259. https://doi.org/10.1155/2017/7203259
Mak, W. W. S., Poon, C. Y. M., Pun, L. Y. K., & Cheung, S. F. (2007). Meta-analysis of stigma
and mental health. Social Science & Medicine, 65(2), 245–261.
https://doi.org/10.1016/j.socscimed.2007.03.015
Makita, M., Mas-Bleda, A., Stuart, E., & Thelwall, M. (2019). Ageing, old age and older adults:
A social media analysis of dominant topics and discourses. Ageing & Society, 1–26.
https://doi.org/10.1017/S0144686X19001016
Mandir, A. S., & Vaughan, C. (2000). Pathophysiology of Parkinson’s disease. International
Review of Psychiatry, 12(4), 270–280. https://doi.org/10.1080/09540260020002497

72

Marras, C., Beck, J. C., Bower, J. H., Roberts, E., Ritz, B., Ross, G. W., Abbott, R. D., Savica,
R., Eeden, S. K. V. D., Willis, A. W., & Tanner, C. M. (2018). Prevalence of Parkinson’s
disease across North America. Npj Parkinson’s Disease, 4(1), 21.
https://doi.org/10.1038/s41531-018-0058-0
Marsh, L. (2013). Depression and Parkinson’s Disease: Current knowledge. Current Neurology
and Neuroscience Reports, 13(12), 409. https://doi.org/10.1007/s11910-013-0409-5
Martens, K. A. E., Hall, J. M., Gilat, M., Georgiades, M. J., Walton, C. C., & Lewis, S. J. G.
(2016). Anxiety is associated with freezing of gait and attentional set-shifting in
Parkinson’s disease: A new perspective for early intervention. Gait & Posture, 49, 431–
436. https://doi.org/10.1016/j.gaitpost.2016.07.182
Martínez-Horta, S., Riba, J., de Bobadilla, R. F., Pagonabarraga, J., Pascual-Sedano, B.,
Antonijoan, R. M., Romero, S., Mañanas, M. À., García-Sanchez, C., & Kulisevsky, J.
(2014). Apathy in Parkinson’s disease: Neurophysiological evidence of impaired
incentive processing. The Journal of Neuroscience, 34(17), 5918–5926.
https://doi.org/10.1523/JNEUROSCI.0251-14.2014
Martínez-Martín, P., Forjaz, M. J., Frades-Payo, B., Rusiñol, A. B., Fernández-García, J. M.,
Benito-León, J., Arillo, V. C., Barberá, M. A., Sordo, M. P., & Catalán, M. J. (2007).
Caregiver burden in Parkinson’s disease. Movement Disorders, 22(7), 924–931.
https://doi.org/10.1002/mds.21355
Martinez‐Martin, P., Schapira, A. H. V., Stocchi, F., Sethi, K., Odin, P., MacPhee, G., Brown, R.
G., Naidu, Y., Clayton, L., Abe, K., Tsuboi, Y., MacMahon, D., Barone, P., Rabey, M.,
Bonuccelli, U., Forbes, A., Breen, K., Tluk, S., Olanow, C. W., … Chaudhuri, K. R.
(2007). Prevalence of nonmotor symptoms in Parkinson’s disease in an international

73

setting; Study using nonmotor symptoms questionnaire in 545 patients. Movement
Disorders, 22(11), 1623–1629. https://doi.org/10.1002/mds.21586
Martinez-Martin, P., Serrano-Dueñas, M., Forjaz, M. J., & Serrano, M. S. (2007). Two
questionnaires for Parkinson’s disease: Are the PDQ-39 and PDQL equivalent? Quality
of Life Research: An International Journal of Quality of Life Aspects of Treatment, Care
and Rehabilitation, 16(7), 1221–1230. https://doi.org/10.1007/s11136-007-9224-2
Maselko, J., & Kubzansky, L. D. (2006). Gender differences in religious practices, spiritual
experiences and health: Results from the US General Social Survey. Social Science &
Medicine, 62(11), 2848–2860. https://doi.org/10.1016/j.socscimed.2005.11.008
Massimo, L., Kales, H. C., & Kolanowski, A. (2018). State of the science: Apathy as a model for
investigating behavioral and psychological symptoms in dementia. Journal of the
American Geriatrics Society, 66(S1), S4–S12. https://doi.org/10.1111/jgs.15343
McNulty, K., Livneh, H., & Wilson, L. M. (2004). Perceived uncertainty, spiritual well-being,
and psychosocial adaptation in individuals with Multiple Sclerosis. Rehabilitation
Psychology, 49(2), 91–99. https://doi.org/10.1037/0090-5550.49.2.91
Meyer, I. H. (2003). Prejudice, social stress, and mental health in lesbian, gay, and bisexual
populations: Conceptual issues and research evidence. Psychological Bulletin, 129(5),
674–697. https://doi.org/10.1037/0033-2909.129.5.674
Meyer, I. H., Schwartz, S., & Frost, D. M. (2008). Social patterning of stress and coping: Does
disadvantaged social status confer more stress and fewer coping resources? Social
Science & Medicine, 67(3), 368–379. https://doi.org/10.1016/j.socscimed.2008.03.012

74

Miller, I. N., & Cronin-Golomb, A. (2010). Gender differences in Parkinson’s disease: Clinical
characteristics and cognition. Movement Disorders, 25(16), 2695–2703.
https://doi.org/10.1002/mds.23388
Mirowsky, J., & Ross, C. E. (1992). Age and depression. Journal of Health and Social Behavior,
33(3), 187–205. JSTOR. https://doi.org/10.2307/2137349
Moore, S., & Knowles, S. (2006). Beliefs and Knowledge about Parkinson’s Disease. E-Journal
of Applied Psychology, 2(1), 15–21. https://doi.org/10.7790/ejap.v2i1.32
Morens, D. M., Grandinetti, A., Davis, J. W., Ross, G. W., White, L. R., & Reed, D. (1996).
Evidence against the operation of selective mortality in explaining the association
between cigarette smoking and reduced occurrence of idiopathic Parkinson disease.
American Journal of Epidemiology, 144(4), 400–404.
https://doi.org/10.1093/oxfordjournals.aje.a008941
Mosley, P. E., Moodie, R., & Dissanayaka, N. (2017). Caregiver burden in Parkinson Disease: A
critical review of recent literature. Journal of Geriatric Psychiatry and Neurology, 30(5),
235–252. https://doi.org/10.1177/0891988717720302
Muangpaisan, W., Mathews, A., Hori, H., & Seidel, D. (2011). A systematic review of the
worldwide prevalence and incidence of Parkinson’s disease. Journal of the Medical
Association of Thailand, 94(6), 749–755.
Narayanasamy, A. (2002). Spiritual coping mechanisms in chronically ill patients. British
Journal of Nursing, 11(22), 1461–1470. https://doi.org/10.12968/bjon.2002.11.22.10957
Newmann, J. P. (1984). Sex differences in symptoms of depression: Clinical disorder or normal
distress? Journal of Health and Social Behavior, 25(2), 136–159. JSTOR.
https://doi.org/10.2307/2136665

75

Nichols, L., & Hunt, B. (2011). The significance of spirituality for individuals with chronic
illness: Implications for mental health counseling. Journal of Mental Health Counseling,
33(1), 51–66. https://doi.org/10.17744/mehc.33.1.025544189523j738
NINDS. (2019). Parkinson’s disease information page. National Institute of Neurological
Disorders and Stroke. https://www.ninds.nih.gov/Disorders/All-Disorders/ParkinsonsDisease-Information-Page
Norris, F. H., Perilla, J. L., Ibañez, G. E., & Murphy, A. D. (2001). Sex differences in symptoms
of posttraumatic stress: Does culture play a role? Journal of Traumatic Stress, 14(1), 7–
28. https://doi.org/10.1023/A:1007851413867
Nussbaum, R. L., & Ellis, C. E. (2003). Alzheimer’s Disease and Parkinson’s Disease. The New
England Journal of Medicine, 348, 1356–1364.
Oguru, M., Tachibana, H., Toda, K., Okuda, B., & Oka, N. (2010). Apathy and depression in
Parkinson disease. Journal of Geriatric Psychiatry and Neurology, 23(1), 35–41.
https://doi.org/10.1177/0891988709351834
Ojeda, L., & Piña-Watson, B. (2013). Day laborers’ life satisfaction: The role of familismo,
spirituality, work, health, and discrimination. Cultural Diversity and Ethnic Minority
Psychology, 19(3), 270–278. https://doi.org/10.1037/a0032961
Oliffe, J. L., Rasmussen, B., Bottorff, J. L., Kelly, M. T., Galdas, P. M., Phinney, A., &
Ogrodniczuk, J. S. (2013). Masculinities, work, and retirement among older men who
experience depression. Qualitative Health Research, 23(12), 1626–1637.
https://doi.org/10.1177/1049732313509408
Owen, A. M., Beksinska, M., James, M., Leigh, P. N., Summers, B. A., Marsden, C. D., Quinn,
N. P., Sahakian, B. J., & Robbins, T. W. (1993). Visuospatial memory deficits at

76

different stages of Parkinson’s disease. Neuropsychologia, 31(7), 627–644.
https://doi.org/10.1016/0028-3932(93)90135-M
Pagonabarraga, J., Kulisevsky, J., Strafella, A. P., & Krack, P. (2015). Apathy in Parkinson’s
disease: Clinical features, neural substrates, diagnosis, and treatment. The Lancet.
Neurology, 14(5), 518–531. https://doi.org/10.1016/S1474-4422(15)00019-8
Palinkas, L. A., Wingard, D. L., & Barrett-Connor, E. (1990). Chronic illness and depressive
symptoms in the elderly: A population-based study. Journal of Clinical Epidemiology,
43(11), 1131–1141. https://doi.org/10.1016/0895-4356(90)90014-G
Pascoe, E. A., & Smart Richman, L. (2009). Perceived discrimination and health: A metaanalytic review. Psychological Bulletin, 135(4), 531–554.
https://doi.org/10.1037/a0016059
Paul, G., Paul, B. S., Gautam, P. L., Singh, G., & Kaushal, S. (2019). Parkinson’s Disease in
intensive care unit: An observational study of frequencies, causes, and outcomes. Annals
of Indian Academy of Neurology, 22(1), 79–83.
https://doi.org/10.4103/aian.AIAN_44_18
Peto, V., Jenkinson, C., & Fitzpatrick, R. (1998). PDQ-39: A review of the development,
validation and application of a Parkinson’s disease quality of life questionnaire and its
associated measures. Journal of Neurology, 245, S10-14.
Peto, V., Jenkinson, C., & Fitzpatrick, R. (2001). Determining minimally important differences
for the PDQ-39 Parkinson’s disease questionnaire. Age and Ageing, 30(4), 299–302.
https://doi.org/10.1093/ageing/30.4.299
Peto, V., Jenkinson, C., Fitzpatrick, R., & Greenhall, R. (1995). The development and validation
of a short measure of functioning and well being for individuals with Parkinson’s disease.

77

Quality of Life Research: An International Journal of Quality of Life Aspects of
Treatment, Care and Rehabilitation, 4(3), 241–248.
Petrou, M., Dwamena, B. A., Foerster, B. R., MacEachern, M. P., Bohnen, N. I., Muller, M.,
Albin, R. L., & Frey, K. A. (2015). Amyloid deposition in Parkinson Disease and
Cognitive Impairment: A Systematic Review. Movement Disorders, 30(7), 928–935.
https://doi.org/10.1002/mds.26191
Petrou, M., Dwamena, B. A., Foerster, B. R., MacEachern, M. P., Bohnen, N. I., Müller, M. L.,
Albin, R. L., & Frey, K. A. (2015). Amyloid deposition in Parkinson’s disease and
cognitive impairment: A systematic review. Movement Disorders, 30(7), 928–935.
https://doi.org/10.1002/mds.26191
Pfeiffer, R. F. (2016). Non-motor symptoms in Parkinson’s disease. Parkinsonism & Related
Disorders, 22, S119–S122. https://doi.org/10.1016/j.parkreldis.2015.09.004
Piderman, K. M., Lapid, M. I., Stevens, S. R., Ryan, S. M., Somers, K. J., Kronberg, M. T.,
Clark, M. M., & Rummans, T. A. (2011). Spiritual well-being and spiritual practices in
elderly depressed psychiatric inpatients. The Journal of Pastoral Care & Counseling,
65(1–2), 3:1-11.
Pluck, G. C., & Brown, R. G. (2002). Apathy in Parkinson’s disease. Journal of Neurology,
Neurosurgery & & Psychiatry, 73(6), 636–642. https://doi.org/10.1136/jnnp.73.6.636
Poewe, W. (2006). The natural history of Parkinson’s disease. Journal of Neurology, 253 Suppl
7, VII2-6. https://doi.org/10.1007/s00415-006-7002-7
Pontone, G. M., Williams, J. R., Anderson, K., Chase, G., Goldstein, S., Grill, S., Hirsch, E. S.,
Lehmann, S., Little, J. T., Margolis, R. L., Rabins, P. V., Weiss, H., & Marsh, L. (2009).

78

Prevalence of anxiety disorders and anxiety subtypes in patients with Parkinson’s
Disease. Movement Disorders, 24(9), 1333–1338. https://doi.org/10.1002/mds.22611
Postuma, R. B., Berg, D., Stern, M., Poewe, W., Olanow, C. W., Oertel, W., Obeso, J., Marek,
K., Litvan, I., Lang, A. E., Halliday, G., Goetz, C. G., Gasser, T., Dubois, B., Chan, P.,
Bloem, B. R., Adler, C. H., & Deuschl, G. (2015). MDS clinical diagnostic criteria for
Parkinson’s disease. Movement Disorders, 30(12), 1591–1601.
https://doi.org/10.1002/mds.26424
Pringsheim, T., Jette, N., Frolkis, A., & Steeves, T. D. L. (2014). The prevalence of Parkinson’s
disease: A systematic review and meta-analysis. Movement Disorders, 29(13), 1583–
1590. https://doi.org/10.1002/mds.25945
Prizer, L. P., Kluger, B. M., Sillau, S., Katz, M., Galifianakis, N., & Miyasaki, J. M. (2019).
Correlates of spiritual wellbeing in persons living with Parkinson disease. Annals of
Palliative Medicine. https://doi.org/10.21037/apm.2019.09.13
Quelhas, R., & Costa, M. (2009). Anxiety, depression, and quality of life in Parkinson’s Disease.
The Journal of Neuropsychiatry and Clinical Neurosciences, 21(4), 413–419.
https://doi.org/10.1176/jnp.2009.21.4.413
Rana, A. Q., Qureshi, A. R. M., Rahman, N., Mohammed, A., Sarfraz, Z., & Rana, R. (2017).
Disability from pain directly correlated with depression in Parkinson’s disease. Clinical
Neurology and Neurosurgery, 160, 1–4. https://doi.org/10.1016/j.clineuro.2017.05.022
Rao, G., Fisch, L., Srinivasan, S., D’Amico, F., Okada, T., Eaton, C., & Robbins, C. (2003).
Does this patient have Parkinson disease? JAMA, 289(3), 347–353.
https://doi.org/10.1001/jama.289.3.347

79

Ravenek, M. J., & Schneider, M. A. (2009). Social support for physical activity and perceptions
of control in early Parkinson’s disease. Disability and Rehabilitation, 31(23), 1925–1936.
https://doi.org/10.1080/09638280902850261
Reitzes, D. C., Mutran, E. J., & Fernandez, M. E. (1996). Does retirement hurt well-being?
Factors influencing self-esteem and depression among retirees and workers. The
Gerontologist, 36(5), 649–656. https://doi.org/10.1093/geront/36.5.649
Reynolds, D. (2017). Spirituality as a coping mechanism for individuals with Parkinson’s
Disease. Journal of Christian Nursing, 34(3), 190.
https://doi.org/10.1097/CNJ.0000000000000392
Ricciardi, L., Bologna, M., Morgante, F., Ricciardi, D., Morabito, B., Volpe, D., Martino, D.,
Tessitore, A., Pomponi, M., Bentivoglio, A. R., Bernabei, R., & Fasano, A. (2015).
Reduced facial expressiveness in Parkinson’s disease: A pure motor disorder? Journal of
the Neurological Sciences, 358(1–2), 125–130. https://doi.org/10.1016/j.jns.2015.08.1516
Roberto, K. A., Mccann, B. R., Blieszner, R., & Savla, J. (2019). A long and winding road:
Dementia caregiving with grit and grace. Innovation in Aging, 3(3), 1–12.
https://doi.org/10.1093/geroni/igz021
Rocca, W. A. (2018). Global, regional, and national burden of Parkinson’s disease, 1990–2016:
A systematic analysis for the Global Burden of Disease Study 2016. The Lancet
Neurology, 17(11), 939–953. https://doi.org/10.1016/S1474-4422(18)30295-3
Roger, K. S., & Hatala, A. (2018). Religion, spirituality & chronic illness: A scoping review and
implications for health care practitioners. Journal of Religion & Spirituality in Social
Work: Social Thought, 37(1), 24–44. https://doi.org/10.1080/15426432.2017.1386151

80

Roger, K. S., & Medved, M. I. (2010). Living with Parkinson’s disease—Managing identity
together. International Journal of Qualitative Studies on Health and Well-Being, 5(2).
https://doi.org/10.3402/qhw.v5i2.5129
Rowe, M. M., & Allen, R. G. (2004). Spirituality as a means of coping with chroic illness.
American Journal of Health Studies, 19(1), 62–67.
Savica, R., Grossardt, B. R., Rocca, W. A., & Bower, J. H. (2018). Parkinson disease with and
without Dementia: A prevalence study and future projections. Movement Disorders,
33(4), 537–543. https://doi.org/10.1002/mds.27277
Schrag, A., Hovris, A., Morley, D., Quinn, N., & Jahanshahi, M. (2003). Young- versus olderonset Parkinson’s disease: Impact of disease and psychosocial consequences. Movement
Disorders, 18(11), 1250–1256. https://doi.org/10.1002/mds.10527
Schreurs, K. M. G., De Ridder, D. T. D., & Bensing, J. M. (2000). A one year study of coping,
social support and quality of life in Parkinson’s Disease. Psychology & Health, 15(1),
109–121. https://doi.org/10.1080/08870440008400292
Shafranske, E. P., & Malony, H. N. (1990). Clinical psychologists’ religious and spiritual
orientations and their practice of psychotherapy. Psychotherapy: Theory, Research,
Practice, Training, 27(1), 72–78. https://doi.org/10.1037/0033-3204.27.1.72
Shaw, A., Joseph, S., & Linley, P. A. (2005). Religion, spirituality, and posttraumatic growth: A
systematic review. Mental Health, Religion & Culture, 8(1), 1–11.
https://doi.org/10.1080/1367467032000157981
Sheikh, J. I., & Yesavage, J. A. (1986). Geriatric Depression Scale (GDS): Recent evidence and
development of a shorter version. Clinical Gerontologist: The Journal of Aging and
Mental Health, 5(1–2), 165–173. https://doi.org/10.1300/J018v05n01_09

81

Shulman, L. M., Armstrong, M., Ellis, T., Gruber-Baldini, A., Horak, F., Nieuwboer, A.,
Parashos, S., Post, B., Rogers, M., Siderowf, A., Goetz, C. G., Schrag, A., Stebbins, G.
T., & Martinez-Martin, P. (2016). Disability rating scales in Parkinson’s Disease:
Critique and recommendations. Movement Disorders, 31(10), 1455–1465.
https://doi.org/10.1002/mds.26649
Siegel, K., & Schrimshaw, E. W. (2002). The perceived benefits of religious and spiritual coping
among older adults living with HIV/AIDS. Journal for the Scientific Study of Religion,
41(1), 91–102. https://doi.org/10.1111/1468-5906.00103
Simpson, J., Haines, K., Lekwuwa, G., Wardle, J., & Crawford, T. (2006). Social support and
psychological outcome in people with Parkinson’s disease: Evidence for a specific
pattern of associations. British Journal of Clinical Psychology, 45(4), 585–590.
https://doi.org/10.1348/014466506X96490
Solimeo, S. (2008). Sex and gender in older adults’ experience of Parkinson’s disease. The
Journals of Gerontology: Series B, 63(1), S42–S48.
https://doi.org/10.1093/geronb/63.1.S42
Soundy, A., Stubbs, B., & Roskell, C. (2014). The experience of Parkinson’s disease: A
systematic review and meta-ethnography. The Scientific World Journal, 2014, 613592.
https://doi.org/10.1155/2014/613592
Spitzer, R. L., Kroenke, K., Williams, J. B. W., & Löwe, B. (2006). A brief measure for
assessing generalized anxiety disorder: The GAD-7. Archives of Internal Medicine,
166(10), 1092–1097. https://doi.org/10.1001/archinte.166.10.1092

82

Starkstein, S. E., Bolduc, P. L., Preziosi, T. J., & Robinson, R. G. (1989). Cognitive impairments
in different stages of Parkinson’s disease. The Journal of Neuropsychiatry and Clinical
Neurosciences, 1(3), 243–248. https://doi.org/10.1176/jnp.1.3.243
Starkstein, S. E., Mayberg, H. S., Preziosi, T. J., Andrezejewski, P., Leiguarda, R., & Robinson,
R. G. (1992). Reliability, validity, and clinical correlates of apathy in Parkinson’s disease.
The Journal of Neuropsychiatry and Clinical Neurosciences, 4(2), 134–139.
https://doi.org/10.1176/jnp.4.2.134
Starkstein, S. E., Robinson, R. G., Leiguarda, R., & Preziosi, T. J. (1993). Anxiety and
depression in Parkinson’s disease. Behavioural Neurology, 6(3), 151–154.
https://doi.org/10.1155/1993/539179
Starkstein, Sergio E. (2012). Apathy in Parkinson’s disease: Diagnostic and etiological
dilemmas. Movement Disorders, 27(2), 174–178. https://doi.org/10.1002/mds.24061
Steele, L. S., Dewa, C. S., Lin, E., & Lee, K. L. K. (2007). Education level, income level and
mental health services use in Canada: Associations and policy implications. Healthcare
Policy, 3(1), 96–106.
Stevens, L. F., Perrin, P. B., Gulin, S., Rogers, H. L., Villaseñor Cabrera, T., JiménezMaldonado, M., & Arango-Lasprilla, J. C. (2013). Examining the influence of three types
of social support on the mental health of mexican caregivers of individuals with traumatic
brain injury. American Journal of Physical Medicine & Rehabilitation, 92(11), 959–967.
https://doi.org/10.1097/PHM.0b013e31828cd549
Styrke, J., Sojka, P., Bjornstig, U., Bylund, P.-O., & Stålnacke, B.-M. (2013). Sex-differences in
symptoms, disability, and life satisfaction three years after mild traumatic brain injury: A

83

population-based cohort study. Journal of Rehabilitation Medicine, 45(8), 749–757.
https://doi.org/10.2340/16501977-1215
Suchowersky, O., Gronseth, G., Perlmutter, J., Reich, S., Zesiewicz, T., Weiner, W. J., & Quality
Standards Subcommittee of the American Academy of Neurology. (2006). Practice
parameter: Neuroprotective strategies and alternative therapies for Parkinson disease (an
evidence-based review): report of the Quality Standards Subcommittee of the American
Academy of Neurology. Neurology, 66(7), 976–982.
https://doi.org/10.1212/01.wnl.0000206363.57955.1b
Sutter, M., & Perrin, P. B. (2016). Discrimination, mental health, and suicidal ideation among
LGBTQ people of color. Journal of Counseling Psychology, 63(1), 98–105.
https://doi.org/10.1037/cou0000126
Takahashi, K., Kamide, N., Suzuki, M., & Fukuda, M. (2016). Quality of life in people with
Parkinson’s disease: The relevance of social relationships and communication. Journal of
Physical Therapy Science, 28(2), 541–546. https://doi.org/10.1589/jpts.28.541
Thangavelu, K., Talk, A. C., Clark, G. I., & Dissanayaka, N. N. W. (2020). Psychosocial factors
and perceived tremor disability in essential tremor. Neuroscience & Biobehavioral
Reviews, 108, 246–253. https://doi.org/10.1016/j.neubiorev.2019.10.021
Tickle-Degnen, L., Zebrowitz, L. A., & Ma, H. (2011). Culture, gender and health care stigma:
Practitioners’ response to facial masking experienced by people with Parkinson’s disease.
Social Science & Medicine, 73(1), 95–102.
https://doi.org/10.1016/j.socscimed.2011.05.008
Tolosa, E., Wenning, G., & Poewe, W. (2006). The diagnosis of Parkinson’s disease. The
Lancet. Neurology, 5(1), 75–86. https://doi.org/10.1016/S1474-4422(05)70285-4

84

Treloar, L. L. (2002). Disability, spiritual beliefs and the church: The experiences of adults with
disabilities and family members. Journal of Advanced Nursing, 40(5), 594–603.
https://doi.org/10.1046/j.1365-2648.2002.02417.x
Tysnes, O.-B., & Storstein, A. (2017). Epidemiology of Parkinson’s disease. Journal of Neural
Transmission, 124(8), 901–905. https://doi.org/10.1007/s00702-017-1686-y
Unantenne, N., Warren, N., Canaway, R., & Manderson, L. (2013). The strength to cope:
Spirituality and faith in chronic disease. Journal of Religion and Health, 52(4), 1147–
1161. https://doi.org/10.1007/s10943-011-9554-9
Walsh, K., & Bennett, G. (2001). Parkinson’s disease and anxiety. Postgraduate Medical
Journal, 77(904), 89–93. https://doi.org/10.1136/pmj.77.904.89
Wang, P. S., Berglund, P., & Kessler, R. C. (2000). Recent care of common mental disorders in
the United States. Journal of General Internal Medicine, 15(5), 284–292.
https://doi.org/10.1046/j.1525-1497.2000.9908044.x
Wee, N., Kandiah, N., Acharyya, S., Chander, R. J., Ng, A., Lok Au, W., & Tan, L. C. S. (2016).
Baseline predictors of worsening apathy in Parkinson’s disease: A prospective
longitudinal study. Parkinsonism & Related Disorders, 23, 95–98.
https://doi.org/10.1016/j.parkreldis.2015.12.004
Weiner, M. R., Monin, J. K., Mota, N., & Pietrzak, R. H. (2016). Age differences in the
association of social support and mental health in male U.S. Veterans: Results from the
National Health and Resilience in Veterans Study. The American Journal of Geriatric
Psychiatry, 24(4), 327–336. https://doi.org/10.1016/j.jagp.2015.11.007
Weintraub, D., & Burn, D. J. (2011). Parkinson’s disease: The quintessential neuropsychiatric
disorder. Movement Disorders, 26(6), 1022–1031. https://doi.org/10.1002/mds.23664

85

Wermuth, L., Stenager, E. N., Stenager, E., & Boldsen, J. (1995). Mortality in patients with
Parkinson’s disease. Acta Neurologica Scandinavica, 92(1), 55–58.
https://doi.org/10.1111/j.1600-0404.1995.tb00466.x
White, A. M., Philogene, G. S., Fine, L., & Sinha, S. (2009). Social support and self-reported
health status of older adults in the United States. American Journal of Public Health,
99(10), 1872–1878. https://doi.org/10.2105/AJPH.2008.146894
Williams, J. R., Hirsch, E. S., Anderson, K., Bush, A. L., Goldstein, S. R., Grill, S., Lehmann, S.,
Little, J. T., Margolis, R. L., Palanci, J., Pontone, G., Weiss, H., Rabins, P., & Marsh, L.
(2012). A comparison of nine scales to detect depression in Parkinson disease.
Neurology, 78(13), 998–1006. https://doi.org/10.1212/WNL.0b013e31824d587f
Wyke, S., Hunt, K., & Ford, G. (1998). Gender differences in consulting a general practitioner
for common symptoms of minor illness. Social Science & Medicine, 46(7), 901–906.
https://doi.org/10.1016/S0277-9536(97)00217-7
Yang, S., Sajatovic, M., & Walter, B. L. (2012). Psychosocial interventions for depression and
anxiety in Parkinson’s Disease. Journal of Geriatric Psychiatry and Neurology, 25(2),
113–121. https://doi.org/10.1177/0891988712445096
Zeligman, M., Varney, M., Grad, R. I., & Huffstead, M. (2018). Posttraumatic growth in
individuals with chronic illness: The role of social support and meaning making. Journal
of Counseling & Development, 96(1), 53–63. https://doi.org/10.1002/jcad.12177
Zhu, K., Hilten, J. J. van, & Marinus, J. (2017). Onset and evolution of anxiety in Parkinson’s
disease. European Journal of Neurology, 24(2), 404–411.
https://doi.org/10.1111/ene.13217

86

Appendix A
Parkinson’s Disease Questionnaires-39 (PDQ-39)
Due to having Parkinson’s disease, how often have you experienced the following, during the
last month?
Never

M
M
M
M
M
M
M
M
E
M
M
M
M
M
M
M
E
E
E
E
E
E

1. Had difficulty doing the leisure
activities you would like to do?
2. Had difficulty looking after your
home, for example, housework,
cooking or yardwork?
3. Had difficulty carrying grocery
bags?
4. Had problems walking half a mile?
5. Had problems walking 100 yards
(approximately 1 block)?
6. Had problems getting around the
house as easily as you would like?
7. Had difficulty getting around in
public places?
8. Needed someone else to accompany
you when you went out?
9. Felt frightened or worried about
falling in public?
10. Been confined to the house more
than you would like?
11. Had difficulty showering and
bathing?
12. Had difficulty dressing?
13. Had difficulty with buttons or
shoelaces?
14. Had problems writing clearly?
15. Had difficulty cutting up your
food?
16. Had difficulty holding a drink
without spilling it?
17. Felt depressed?
18. Felt isolated and lonely?
19. Felt weepy or tearful?
20. Felt angry or bitter?
21. Felt anxious?
22. Felt worried about your future?

Occasionally Sometimes

Often

Always

0

1

2

3

4

0

1

2

3

4

0

1

2

3

4

0

1

2

3

4

0

1

2

3

4

0

1

2

3

4

0

1

2

3

4

0

1

2

3

4

0

1

2

3

4

0

1

2

3

4

0

1

2

3

4

0

1

2

3

4

0

1

2

3

4

0

1

2

3

4

0

1

2

3

4

0

1

2

3

4

0

1

2

3

4

0
0
0
0
0
0

1
1
1
1
1
1

2
2
2
2
2
2

3
3
3
3
3
3

4
4
4
4
4
4
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23. Felt you had to hide your
0
1
2
Parkinson's from people?
24. Avoided situations which involve
ST
0
1
2
eating or drinking in public?
ST 25. Felt embarrassed in public?
0
1
2
26. Felt worried about other people's
ST
0
1
2
reaction to you?
27. Had problems with your close
Ss
0
1
2
personal relationships?
28. Lacked the support you needed
Ss
0
1
2
from your spouse or partner?
29. Lacked the support you needed
Ss
0
1
2
from your family or close friends?
30. Unexpectedly fallen asleep during
N
0
1
2
the day?
31. Had problems with your
E
concentration, for example when
0
1
2
reading or watching TV?
E
32. Felt your memory was failing?
0
1
2
33. Had distressing dreams or
E
0
1
2
hallucinations?
M
34. Had difficulty speaking?
0
1
2
35. Felt unable to communicate
N
0
1
2
effectively?
E
36. Felt ignored by people?
0
1
2
37. Had painful muscle cramps or
N
0
1
2
spasms?
38. Had aches and pains in your joints
N
0
1
2
or body?
E
39. Felt uncomfortably hot or cold?
0
1
2
Note: M = motor PD symptom; N = non-motor PD symptom; E = excluded; ST = Stigma
Subscale; Ss = Social Support subscale
ST

3

4

3

4

3

4

3

4

3

4

3

4

3

4

3

4

3

4

3

4

3

4

3

4

3

4

3

4

3

4

3

4

3

4
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Appendix B
Non-Motor Symptoms Questionnaire (NMS)
The movement symptoms of Parkinson’s are well known. However, other problems can
sometimes occur as part of the condition or its treatment. It is important that the doctor knows
about these, particularly if they are troublesome for you.
A range of problems is listed below. Please tick the box ‘Yes’ if you have experienced it during
the past month. The doctor or nurse may ask you some questions to help decide. If you have not
experienced the problem in the past month tick the ‘No’ box. You should answer ‘No’ even if
you have had the problem in the past but not in the past month.
Have you experienced any of the following in the last month?

M
N
M
N
N
N
N
N
N
N
N
N
E

1. Dribbling of saliva during the
daytime
2. Loss or change in your ability to
taste or smell
3. Difficulty swallowing food or drink
or problems with choking
4. Vomiting or feelings of sickness
(nausea)
5. Constipation (less than three bowel
movements a week) or having to strain
to pass stool (feces)
6. Bowel (fecal) incontinence
7. Feeling that your bowel emptying is
incomplete after having been to the
toilet
8. A sense of urgency to pass urine
makes you rush to the toilet
9. Getting up regularly at night to pass
urine
10. Unexplained pains (not due to
known conditions such as arthritis)
11. Unexplained change in weight (not
due to change in diet)
12. Problems remembering things that
have happened recently or forgetting to
do things.
13. Loss of interest in what is
happening around you or doing things

Yes

No

Yes

No

Yes

No

Yes

No

Yes

No

Yes

No

Yes

No

Yes

No

Yes

No

Yes

No

Yes

No

Yes

No

Yes

No

Yes

No
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14. Seeing or hearing things that you
Yes
No
know or are told are not there
15. Difficulty concentrating or staying
N
Yes
No
focused.
16. Feeling sad, "low" or "blue"
E
Yes
No
17. Feeling anxious, frightened, or
E
Yes
No
panicky
18. Feeling less interested in sex or
E
Yes
No
more interested in sex
19. Finding it difficult to have sex
E
Yes
No
when you try
20. Feeling lightheaded, dizzy or weak
N
Yes
No
standing from sitting or lying
21. Falling
M
Yes
No
22. Finding it difficult to stay awake
N
during activities such as working,
Yes
No
driving or eating
23. Difficulty getting to sleep at night
N
Yes
No
or staying asleep at night
24. Intense, vivid dreams or frightening
N
Yes
No
dreams
25. Talking or moving about in your
N
Yes
No
sleep as if you are "acting" out a dream
26. Unpleasant sensations in your legs
N
at night or while resting, and a feeling
Yes
No
that you need to move
27. Swelling of your legs
N
Yes
No
28. Excessive sweating
N
Yes
No
29. Double vision
N
Yes
No
30. Believing things are happening to
N
Yes
No
you that other people say are not true
Note: M = motor PD symptom; N = non-motor PD symptom; E = excluded
N
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Appendix C
Apathy Scale (AS)
For each question, please place a mark in the response that best describes you.

1. Are you interested in learning new things?
2. Does anything interest you? (Excluded)
3. Are you concerned about your condition?
4. Do you put much effort into things?
5. Are you always looking for something to do?
6. Do you have plans and goals for the future?
7. Do you have motivation?
8. Do you have the energy for daily activities? (Excluded)
9. Does someone have to tell you what to do each day?
10. Are you indifferent to things?
11. Are you unconcerned with many things?
12. Do you need a push to get started on things?
13. Are you neither happy nor sad, just in between?
14. Would you consider yourself apathetic?

Not at
all
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

Slightly

Some

A lot

1
1
1
1
1
1
1
1
1
1
1
1
1
1
1

2
2
2
2
2
2
2
2
2
2
2
2
2
2
2

3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
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Appendix D
Generalized Anxiety Disorder-7 (GAD-7)
Over the last 2 weeks, how often have you been bothered by any of the following problems?

1. Feeling nervous, anxious, or on edge
2. Not being able to stop or control worrying
3. Worrying too much about different things
4. Trouble relaxing
5. Being so restless that it’s hard to sit still
6. Being easily annoyed or irritable
7. Being afraid as if something awful might happen

Not at
all

Several
days

0
0
0
0
0
0
0
0

1
1
1
1
1
1
1
1

More
than
half the
days
2
2
2
2
2
2
2
2

Nearly
every
day
3
3
3
3
3
3
3
3

If you checked off any problem on this questionnaire so far, how difficult have these problems
made it for you to do your work, take care of things at home, or get along with other people?
Not Difficult At All
0

Somewhat Difficult
1

Very Difficult
2

Extremely Difficult
3
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Appendix E
Beck Anxiety Inventory (BAI)
Below is a list of common symptoms of anxiety. Please carefully read each item in the list.
Indicate how much you have been bothered by that symptom during the past month, including
today, by circling the number in the corresponding space in the column next to each symptom.
Not at all

1. Numbness or tingling
2. Feeling hot (Excluded)
3. Wobbliness in legs (Excluded)
4. Unable to relax
5. Fear of worst happening
6. Dizzy or lightheaded (Excluded)
7. Heart pounding/racing
8. Unsteady (Excluded)
9. Terrified or afraid
10. Nervous
11. Feeling of choking (Excluded)
12. Hands trembling (Excluded)
13. Shaky/unsteady (Excluded)
14. Fear of losing control
15. Difficulty in breathing
16. Fear of dying
17. Scared
18. Indigestion
19. Faint/lightheaded (Excluded)
20. Face flushed
21. Hot/cold sweats (Excluded)

0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

Mildly, but it
didn't bother me
much
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1

Moderately - it
wasn't pleasant
at times
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2

Severely - it
bothered me a
lot
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
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Appendix F
Beck Depression Inventory (BDI)
Below is a list of common symptoms of depression. Please carefully read each item in the list.
Indicate how much you have been bothered by that symptom during the past month, including
today, by circling the number in the corresponding space in the column next to each symptom.
0

1

2

1. Sadness

0. I do not feel sad.

1. I feel sad much of
the time.

2. I am sad all the time.

2. Pessimism

0. I am not
discouraged about my
future.

1. I feel more
discouraged about my
future than I used to
be.

2. I do not expect things to
work out for me.

3. Past Failure

0. I do not feel like a
failure.

1. I have failed more
than I should have.

2. As I look back, I see a lot
of failures.

4. Loss of
Pleasure

0. I get as much
pleasure as I ever did
from the things I
enjoy.

1. I don't enjoy things
as much as I used to.

2. I get very little pleasure
from the things I used to enjoy.

5. Guilty
Feelings

0. I don't feel
particularly guilty.

1. I feel guilty over
many things I have
done or should have
done.

2. I feel quite guilty most of
the time.

6. Punishment
Feelings

0. I don't feel I am
being punished.

1. I feel I may be
punished.

2. I expect to be punished.

7. Self-Dislike

0. I feel the same
about myself as ever.

1. I have lost
confidence in myself.

2. I am disappointed in
myself.

8. SelfCriticalness

0. I don't criticize or
blame myself more
than usual.

1. I am more critical
of myself than I used
to be.

2. I criticize myself for all of
my faults.

9. Suicidal
Thoughts or
Wishes

0. I don't have any
thoughts of killing
myself.

1. I have thoughts of
killing myself, but I
would not carry them
out.

2. I would like to kill myself.

10. Crying

0. I don't cry any more
than I used to.

1. I cry more than I
used to.

2. I cry over every little thing.

3
3. I am so
sad or
unhappy that
I can't stand
it.
3. I feel my
future is
hopeless and
will only get
worse.
3. I feel I am
a total failure
as a person.
3. I can't get
any pleasure
from the
things I used
to enjoy.
3. I feel
guilty all of
the time.
3. I feel I am
being
punished.
3. I dislike
myself.
3. I blame
myself for
everything
bad that
happens.
3. I would
kill myself if
I had the
chance.
3. I feel like
crying, but I
can't.
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3. I am so
restless or
agitated that
I have to
keep moving
or doing
something.
3. It's hard to
get interested
in anything.
3. I have
trouble
making any
decisions.

11. Agitation

0. I am no more
restless or wound up
than usual.

1. I feel more restless
or wound up than
usual.

2. I am so restless or agitated
that it's hard to stay still.

12. Loss of
Interest

0. I have not lost
interest in other people
or activities.

1. I am less interested
in other people or
things than before.

2. I have lost more of my
interest in other people or
things.

13.
Indecisiveness

0. I make decisions
about as well as ever.

1. I find it more
difficult to make
decisions than usual.

2. I have much greater
difficulty in making decisions
than I used to.

14.
Worthlessness

0. I do not feel I am
worthless.

1. I don't consider
myself as worthwhile
and useful as I used
to.

2. I feel more worthless as
compared to other people.

3. I feel
utterly
worthless.

15. Loss of
Energy

0. I have as much
energy as ever.

1. I have less energy
than I used to have.

2. I don't have enough energy
to do very much.

3. I don't
have enough
energy to do
anything.

2. I sleep a lot more than usual
OR I sleep a lot less than
usual.

3. I sleep
most of the
day OR I
wake up 1-2
hours early
and can't get
back to sleep.

16. Changes in
Sleeping
Pattern
(Excluded)

0. I have not
experienced any
change in my sleeping
pattern.

Changes in Sleeping
Pattern: Select the
specific option that
applies to you in Item
16. (Excluded)

0. I have not
experienced
any change in
my sleeping
pattern.

1. I sleep somewhat
more than usual OR I
sleep somewhat less
than usual.

1. I sleep
somewhat
more than
usual.

2. I sleep
somewhat
less than
usual.

3. I
sleep a
lot
more
than
usual.

4. I
sleep a
lot less
than
usual.

17. Irritability

0. I am no more irritable
than usual.

1. I am more irritable
than usual.

18. Changes in Appetite

0. I have not
experienced any change
in my appetite.

1. My appetite is
somewhat less than
usual OR My appetite
is somewhat greater
than usual.

Changes in
appetite: Select the
specific option that

0. I have not
experienced

1. My
appetite is
somewhat

2. My
appetite is
somewhat

3. My
appetite is
much less

5. I
sleep
most
of the
day.

2. I am much
more irritable
than usual.
2. My
appetite is
much less
than before
OR My
appetite is
much greater
than usual.

4. My
appetite
is much

5. I have
no

6. I wake up
1-2 hours
early and
can't get back
to sleep.
3. I am
irritable all
the time.
3. I have no
appetite at all
OR I crave
food all the
time.
6. I crave
food all the
time.
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applies to you in
Item 18.

any change in
my appetite.

less than
usual.

greater
than usual.

than
before.

greater
than
usual.

appetite
at all.

19. Concentration
Difficulty (Excluded)

0. I can
concentrate as
well as ever.

1. I can't concentrate as
well as usual.

2. It's hard to keep
my mind on
anything for very
long.

3. I find I can't
concentrate on
anything.

20. Tiredness or Fatigue

0. I am no more
tired or fatigued
than usual.

1. I get more tired or
fatigued more easily
than usual.

2. I am too tired or
fatigued to do a lot
of the things I used
to do.

3. I am too tired
or fatigued to do
most of the
things I used to
do.

21. Loss of Interest in Sex
(Excluded)

0. I have not
noticed any
recent change
in my interest
in sex.

1. I am less interested in
sex than I used to be.

2. I am much less
interested in sex
now.

3. I have lost
interest in sex
completely.
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Appendix G
Patient Health Questionnare-9 (PHQ-9)
Over the last 2 weeks, how often have you been bothered by any of the following problems?

Not at
all

Several
days

0
0
0

1
1
1

More
than
half the
days
2
2
2

0

1

2

3

0
0

1
1

2
2

3
3

0

1

2

3

7. Trouble concentrating on things such as reading the
newspaper or watching television (Excluded)

0

1

2

3

8. Moving or speaking so slowly that other people could
have noticed. Or being so fidgety or restless that you have
been moving around a lot more than usual

0

1

2

3

9. Thinking that you would be better off dead or that you
want to hurt yourself in some way

0

1

2

3

1. Little interest or pleasure in doing things
2. Feeling down, depressed, or hopeless
3. Trouble falling asleep, staying asleep, or sleeping too
much (Excluded)
4. Feeling tired or having little energy
5. Poor appetite or overeating
6. Feeling bad about yourself, feeling that you are a failure,
or feeling that you have let yourself or your family down

Nearly
every
day
3
3
3

If you checked off any problem on this questionnaire so far, how difficult have these problems
made it for you to do your work, take care of things at home, or get along with other people?
Not Difficult At All
0

Somewhat Difficult
1

Very Difficult
2

Extremely Difficult
3
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Appendix H
Geriatric Depression Scale Short Form (GDS-SF)
Choose the best answer for how you have felt over the past week:

1. Are you basically satisfied with your life?
2. Have you dropped many of your activities and interests?
3. Do you feel that your life is empty?
4. Do you often get bored?
5. Are you in good spirits most of the time?
6. Are you afraid that something bad is going to happen to you
7. Do you feel happy most of the time?
8. Do you often feel helpless?
9. Do you prefer to stay at home, rather than going out and doing new things?
10. Do you feel you have more problems with memory than most? (Excluded)
11. Do you think it is wonderful to be alive now?
12. Do you feel pretty worthless the way you are now?
13. Do you feel full of energy?
14. Do you feel that your situation is hopeless?
15. Do you think that most people are better off than you are?

Yes
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

No
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
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Appendix I
Linear Analogue Self-Assessment (LASA)
Directions: Please circle the number (0-10) best reflecting your response to the following that
best describes your feelings during the past week, including today.
As bad
as it
can be
1
1

2 3
1. How would you rate your physical well-being over
2 3
the past week? This question refers to such things as
fatigue, activity, etc.
2. How would you rate your emotional well-being over
1
2 3
the past week? This question refers to such things as
depression, anxiety, stress, etc.
3. How would you rate your spiritual well-being over
1
2 3
the past week? This question refers to such things as
a sense of meaning and purpose, relationship with
God, etc.
4. How would you rate your intellectual well-being over
1
2 3
the past week? This question refers to such things as the
ability to think clearly, to concentrate, to remember, etc.
5. How would you rate your overall well-being over the
1
2 3
past week?
Note: Bolded item (item number three) is single-item used from this scale.

4 5 6 7 8 9
4 5 6 7 8 9

As good
as it can
be
10
10

4 5 6 7 8 9

10

4 5 6 7 8 9

10

4 5 6 7 8 9

10

4 5 6 7 8 9

10
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